info icon

Lichen planus, including avohilmo

L12_LICHENPLANUS_INCLAVO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 L43

1 out of 7 registries used, show all original rules.

3315

4. Check minimum number of events

None

3315

5. Include endpoints

7461

6. Filter based on genotype QC (FinnGen only)

7461

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF6
Parent code in ICD-10
L40-L45
Name in latin
Lichen planus

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 7461 4936 2525
Unadjusted period prevalence (%) 1.49 1.68 1.11
Median age at first event (years) 60.28 60.44 59.95

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
6602
Matched controls
66021
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L43.0
ICD-10 Finland
Hypertrophic lichen planus
+∞
323.0
755
*
L43
ICD-10 Finland
Lichen planus
+∞
323.0
1376
*
D07AC13
ATC
mometasone; topical
3.1
323.0
2805
12815
L43.8
ICD-10 Finland
Other lichen planus
+∞
323.0
2658
*
EKA10
NOMESCO Finland
Biopsy of cheek
18.6
323.0
768
463
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
37.0
323.0
736
223
L43.9
ICD-10 Finland
Lichen planus, unspecified
+∞
323.0
2800
*
D07AD01
ATC
clobetasol; topical
6.2
323.0
2618
6301
D07AC01
ATC
betamethasone; topical
4.7
323.0
3929
15734
E0000UV
ATC
NA
2.6
285.5
3308
18395
L43.3
ICD-10 Finland
Subacute (active) lichen planus
+∞
285.5
272
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.1
262.3
1788
7086
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
6.8
223.1
598
950
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.6
214.1
1105
3500
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
186.6
2308
12434
L43.1
ICD-10 Finland
Bullous lichen planus
+∞
183.2
175
*
SBA00
NOMESCO Finland
Microbiological examinations
7.2
174.7
447
659
ECA20
NOMESCO Finland
Biopsy of gingiva
14.5
173.7
302
218
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
7.7
152.2
370
504
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
149.6
2753
17211
K13.29
ICD-10 Finland
Indefinite leukoplakia
12.1
139.3
262
225
A07AA02
ATC
nystatin; oral
3.4
131.9
699
2206
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
5.9
128.4
378
669
E000001
ATC
NA
2.2
127.4
1568
8139
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
125.7
2068
12140
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
6.0
124.9
363
632
A01AC01
ATC
triamcinolone; local oral
7.3
123.5
311
445
N77.8*L43.9
ICD-10 Finland
Vulvovaginal ulceration and inflammation caused by lichen ruber planus
91.8
113.4
126
14
L43.2
ICD-10 Finland
Lichenoid drug reaction
+∞
111.8
107
*
D05BB02
ATC
acitretin; oral
5.7
109.3
331
605
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
108.2
4580
36576
69700
ICD-8 Finland
Lichen, Planus
+∞
107.6
103
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
104.8
1725
9983
H02AB06
ATC
prednisolone; systemic
1.7
95.8
3182
23137
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
4.3
93.3
372
913
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
89.4
4079
32241
D07AB08
ATC
desonide; topical
2.4
87.8
829
3714
K13.78
ICD-10 Finland
Other change in the oral mucosa
5.3
86.9
281
554
ULA02
NOMESCO Finland
Kolposcopy
2.5
79.9
686
2915
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
79.5
2231
15159
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.1
78.3
457
1528
SXA10
NOMESCO Finland
Epithel biopsy of mouth
7.4
77.3
190
262
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.2
75.8
429
1403
XQ802
NOMESCO Finland
Epicutan test
3.4
73.1
375
1139
J02AC01
ATC
fluconazole; systemic
1.6
73.1
2697
19652
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
71.6
724
3336
D09AB01
ATC
zinc bandage without supplements; topical
4.9
71.4
244
511
K13.20
ICD-10 Finland
Idiopathic leukoplakia
15.3
71.4
120
80
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
7.2
70.4
176
249
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.9
67.4
450
1644
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
67.3
3491
27515
D07BC01
ATC
betamethasone and antiseptics; topical
2.1
66.4
874
4525
A01AB09
ATC
miconazole; local oral
2.2
65.0
716
3430
L28.0
ICD-10 Finland
Lichen simplex chronicus
7.5
64.7
158
216
TQW80
NOMESCO Finland
Local dermatologic skincare
4.0
63.1
266
686
R06AE07
ATC
cetirizine; oral
1.6
62.8
2789
21029
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
60.0
3278
25844
S29
ICPC
Skin symptom/complaint other
1.8
58.8
1151
6876
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
58.8
2820
21537
R06AX27
ATC
desloratadine; oral
1.7
57.6
1663
11167
WX110
NOMESCO Finland
Local anesthesy
1.5
57.0
4272
35988
J01DB01
ATC
cefalexin; oral
1.6
57.0
5219
46149
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
56.3
3500
28232
B37.08
ICD-10 Finland
Other candidal stomatitis
9.0
55.3
120
136
LEB00
NOMESCO Finland
Biopsy of vagina
4.4
53.4
201
466
R01AD11
ATC
triamcinolone; nasal
2.1
53.3
652
3257
E000002
ATC
NA
2.0
52.4
734
3876
D02AE01
ATC
carbamide; topical
2.3
51.4
497
2226
6970A
ICD-9 Finland
Lichen planus[LICHEN RUBER PLANUS]
+∞
51.1
49
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
50.8
2938
23120
SDA02
NOMESCO Finland
Parodonthologic therapy
1.5
50.5
2032
14745
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.9
50.1
815
4546
K02.1
ICD-10 Finland
Caries of dentine
1.5
49.9
3358
27237
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.5
49.5
2258
16839
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.8
49.1
342
1279
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
16.0
48.2
79
50
R01AD09
ATC
mometasone; nasal
1.5
46.3
2746
21569
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
8.2
46.0
105
130
E000006
ATC
NA
2.1
46.0
535
2607
N77.8
ICD-10 Finland
Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
85.7
45.9
51
6
XQ848
NOMESCO Finland
Dermatological photography
3.4
45.5
230
691
R03AC02
ATC
salbutamol; inhalant
1.4
45.2
3229
26285
A01AB04
ATC
amphotericin B; local oral
2.5
45.0
382
1598
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
44.3
2489
19283
R06AE09
ATC
levocetirizine; oral
1.8
43.3
901
5441
Z01.2
ICD-10 Finland
Dental examination
1.5
43.0
2440
18903
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.6
43.0
1499
10434
S18
ICPC
Laceration/cut
1.4
42.4
2608
20518
M79.6
ICD-10 Finland
Pain in limb
1.5
42.1
2230
17016
A02BC05
ATC
esomeprazole; systemic
1.4
40.7
2577
20332
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
40.7
330
1345
S21
ICPC
Skin texture symptom/complaint
1.8
40.0
803
4785
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
17.2
39.7
63
37
D07CC01
ATC
betamethasone and antibiotics; topical
1.8
39.7
820
4932
D07XC01
ATC
betamethasone, combinations; topical
1.8
38.3
756
4478
N02BE01
ATC
paracetamol; systemic, rectal
1.5
37.2
5510
50640
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
10.2
37.1
74
73
D82
ICPC
Teeth/gum disease
1.5
37.0
1980
15042
J02AC02
ATC
itraconazole; systemic
1.6
37.0
1160
7823
K12.10
ICD-10 Finland
Stomatitis NOS
8.2
36.2
82
101
R01AD08
ATC
fluticasone; nasal
1.5
35.5
1698
12588
J01DA01
ATC
[U] cefalexin; systemic
1.4
35.3
3830
32965
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
35.1
1550
11291
J01AA02
ATC
doxycycline; systemic
1.4
35.0
4952
44653
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
34.3
2629
21270
M25.5
ICD-10 Finland
Pain in joint
1.5
34.0
1715
12830
J01CA04
ATC
amoxicillin; systemic
1.4
33.9
4924
44440
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
33.8
1525
11148
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.7
33.6
799
4994
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
33.3
1252
8791
EMAK
NOMESCO Finland
NA
2.6
33.0
257
1027
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
32.7
2412
19338
A02BC02
ATC
pantoprazole; systemic
1.4
32.2
4073
35676
A02BC03
ATC
lansoprazole; oral
1.4
32.2
1822
13910
M03BX02
ATC
tizanidine; oral
1.4
31.8
3786
32801
D07AA02
ATC
hydrocortisone; topical
1.7
31.2
771
4868
EBA00
NOMESCO Finland
Extraction of tooth
1.4
31.2
1840
14139
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.5
31.0
1434
10511
KMAK
NOMESCO Finland
NA
1.4
30.9
2997
25065
M01AC06
ATC
meloxicam; systemic, rectal
1.4
30.9
2316
18563
-1
NOMESCO Finland
NA
1.4
30.9
1824
14015
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
30.8
1762
13457
E000007
ATC
NA
2.1
30.7
368
1810
N48.1
ICD-10 Finland
Balanoposthitis
3.7
30.7
137
374
L17
ICPC
Foot/toe symptom/complaint
1.4
30.5
1518
11279
D07AC14
ATC
methylprednisolone aceponate; topical
2.2
30.2
323
1515
SPAT1153
SPAT
Removal of sutures
1.4
30.1
1968
15384
WZA90
NOMESCO Finland
Other doctors statement
1.5
29.1
1327
9675
UJF32
NOMESCO Finland
Coloscopy
1.4
29.0
1583
11954
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.4
28.6
1422
10542
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
28.5
659
4074
L30.0
ICD-10 Finland
Nummular dermatitis
2.5
28.4
230
939
M01AH05
ATC
etoricoxib; oral
1.3
28.2
3594
31178
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.4
28.1
1352
9956
EHA10
NOMESCO Finland
Biopsy of palate
6.1
28.0
77
127
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
28.0
2571
21201
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
27.9
1522
11479
XQ800
NOMESCO Finland
Prick test
1.9
27.8
433
2362
H03AA01
ATC
levothyroxine sodium; systemic
1.4
27.7
1489
11199
WX290
NOMESCO Finland
Other blockade of nerve
1.4
27.7
2337
19004
SPAT1263
SPAT
Sampling
1.3
27.5
2478
20349
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
5.1
27.4
88
175
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.8
27.4
496
2847
P01AB01
ATC
metronidazole; oral, rectal
1.3
27.1
2377
19429
N02AX02
ATC
tramadol; systemic, rectal
1.3
27.1
2527
20856
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
27.0
1610
12328
TEA00
NOMESCO Finland
Biopsy of lip
4.6
27.0
96
213
N89.5
ICD-10 Finland
Stricture and atresia of vagina
13.1
26.8
47
36
SPAT1310
SPAT
Counselling related to known health issue
1.4
26.8
1880
14809
M54.5
ICD-10 Finland
Low back pain
1.4
26.7
1898
14984
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
26.4
1406
10542
A98
ICPC
Health maint/preventive medicine
1.7
26.3
6219
59667
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
25.8
2231
18155
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
25.6
539
3240
L66.1
ICD-10 Finland
Lichen planopilaris
21.9
25.6
37
17
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
25.4
3044
25989
D02AX
ATC
Other emollients and protectives
2.5
25.3
206
845
C05AA08
ATC
fluocortolone; rectal, topical
1.5
25.3
872
5964
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
25.3
1506
11506
G01AA10
ATC
clindamycin; vaginal
1.5
25.3
886
6085
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
25.2
790
5283
SPAT1312
SPAT
General health counselling
1.4
25.1
1829
14469
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
25.0
2710
22786
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
24.9
1260
9339
R06.0
ICD-10 Finland
Dyspnoea
1.4
24.7
1418
10758
L28.1
ICD-10 Finland
Prurigo nodularis
4.9
24.7
82
170
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.6
24.6
642
4098
SPAT1301
SPAT
No procedures
1.4
24.5
1852
14720
R01AD01
ATC
beclometasone; nasal
1.5
24.5
896
6210
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.9
24.4
371
2004
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
24.4
1984
15952
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.7
24.4
574
3564
R01AD12
ATC
fluticasone furoate; nasal
1.4
24.3
1615
12564
J01FA10
ATC
azithromycin; systemic
1.3
24.3
3363
29230
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
24.0
2906
24778
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
9.5
23.9
49
52
SPAT1260
SPAT
Consultation of another employee
1.5
23.8
1043
7512
N03AX16
ATC
pregabalin; oral
1.4
23.6
1402
10693
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.6
23.6
665
4330
R05
ICPC
Cough
1.4
23.4
1263
9459
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
23.4
1742
13790
N05BB01
ATC
hydroxyzine; systemic
1.9
23.4
374
2058
K12.00
ICD-10 Finland
Recurrent oral aphthae
3.8
23.1
100
268
D19
ICPC
Teeth/gum symptom/complaint
1.4
22.9
1429
10981
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
22.8
1855
14879
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.1
22.8
256
1229
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
22.6
516
3174
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
4.2
22.4
86
207
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
11.1
22.3
42
38
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.4
22.2
192
814
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
6.0
22.1
61
102
K12.18
ICD-10 Finland
Other forms of stomatitis
4.7
22.1
76
164
L03
ICPC
Low back symptom/complaint
1.4
21.9
1370
10524
S99
ICPC
Skin disease other
2.8
21.9
139
495
TLE00
NOMESCO Finland
Dilatation of vagina
62.7
21.8
25
*
S08
ICPC
Skin colour change
2.0
21.8
301
1567
J01FF01
ATC
clindamycin; systemic
1.4
21.7
1549
12152
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
21.7
1419
10978
L30.8
ICD-10 Finland
Other specified dermatitis
2.8
21.7
143
521
K05.30
ICD-10 Finland
Periodontitis complex
1.5
21.7
717
4850
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
21.6
5563
52382
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
7.4
21.6
51
69
A02BA02
ATC
ranitidine; systemic
1.4
21.5
1159
8661
K05.31
ICD-10 Finland
Periodontitis pronounced
1.6
21.5
570
3650
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
21.2
2551
21603
SFA00
NOMESCO Finland
Small filling
1.5
21.0
731
4997
R06AX22
ATC
ebastine; oral
1.4
21.0
956
6920
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
20.7
1297
9951
D01BA02
ATC
terbinafine; oral; topical
1.4
20.6
1402
10901
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
20.5
676
4568
SBB10
NOMESCO Finland
Teeth copy
1.9
20.5
307
1652
R74
ICPC
Upper respiratory infection acute
1.4
20.2
1381
10744
D07AC03
ATC
desoximetasone; topical
2.9
20.2
124
433
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
20.1
2107
17467
S02
ICPC
Pruritus
2.2
20.1
200
911
EJ2S1
NOMESCO Finland
Photography of oral mucosa
9.0
20.0
42
47
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
20.0
780
5468
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.4
19.9
886
6378
D05AX52
ATC
calcipotriol, combinations; topical
1.9
19.9
318
1750
M01AB05
ATC
diclofenac; systemic, rectal
1.3
19.7
4000
36075
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
19.7
1112
8366
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
6.8
19.7
49
72
L15
ICPC
Knee symptom/complaint
1.4
19.6
1217
9312
VALMI
NOMESCO Finland
NA
1.4
19.5
1284
9919
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
19.4
923
6731
J01MA02
ATC
ciprofloxacin; systemic
1.3
19.4
2184
18267
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
14.6
19.3
32
22
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.7
19.2
422
2566
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
19.2
2197
18400
N03AX12
ATC
gabapentin; oral
1.4
19.2
881
6379
A02BC01
ATC
omeprazole; systemic
1.3
19.0
1583
12678
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
18.9
724
5051
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
18.7
1280
9944
J05AB01
ATC
aciclovir; systemic
1.4
18.7
1168
8937
L08
ICPC
Shoulder symptom/complaint
1.4
18.6
1101
8346
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
18.5
413
2522
L20.0
ICD-10 Finland
Besnier prurigo
1.9
18.3
292
1605
SXC05
NOMESCO Finland
Other oral or dental procedure
1.8
18.2
301
1674
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
18.1
791
5665
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
18.1
568
3791
M01AE02
ATC
naproxen; oral, rectal
1.3
18.1
3255
28785
N06AX11
ATC
mirtazapine; oral
1.3
18.0
1776
14551
G47.3
ICD-10 Finland
Sleep apnoea
1.4
17.9
1121
8576
J01FA09
ATC
clarithromycin; systemic
1.3
17.8
1787
14675
SPAT1325
SPAT
Vaccination
1.3
17.8
1975
16440
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.4
17.7
1174
9062
L30.3
ICD-10 Finland
Infective dermatitis
2.1
17.4
188
889
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
17.1
1027
7790
M01AX05
ATC
glucosamine; oral
1.3
17.0
1249
9792
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
17.0
1051
8019
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
11.5
17.0
31
27
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
17.0
409
2551
R05
ICD-10 Finland
Cough
1.4
16.9
1087
8343
R51.80
ICD-10 Finland
Headache
1.4
16.7
733
5255
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
4.1
16.5
63
153
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
16.4
1575
12824
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
16.4
626
4360
A07EA02
ATC
hydrocortisone; rectal
2.4
16.4
135
560
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
2.8
16.2
104
373
B35.3
ICD-10 Finland
Tinea pedis
2.0
16.2
211
1079
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.7
16.2
333
1987
R52.9
ICD-10 Finland
Pain, unspecified
1.6
16.1
460
3000
K03.66
ICD-10 Finland
Tooth plaque
1.7
16.1
333
1992
M02AA07
ATC
piroxicam; topical
1.3
15.9
2161
18387
N76.1
ICD-10 Finland
Subacute and chronic vaginitis
2.9
15.8
95
329
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
15.8
889
6663
S87
ICPC
Dermatitis/atopic eczema
2.6
15.8
118
465
L13
ICPC
Hip symptom/complaint
1.4
15.8
924
6976
R13
ICD-10 Finland
Dysphagia
1.7
15.7
356
2184
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
15.7
570
3927
L30
ICD-10 Finland
Other dermatitis
2.6
15.7
114
443
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.5
15.6
547
3741
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.6
15.4
444
2901
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
15.3
668
4779
M01AX17
ATC
nimesulide; oral
1.3
15.2
1444
11724
G44.2
ICD-10 Finland
Tension-type headache
1.4
15.1
701
5072
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.5
15.0
460
3047
H02AB04
ATC
methylprednisolone; systemic
1.4
15.0
814
6066
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
15.0
1042
8086
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
14.9
2204
18899
D07AB01
ATC
clobetasone; topical
2.0
14.8
185
933
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.1
14.7
166
801
R03BA05
ATC
fluticasone; inhalant
1.4
14.7
959
7368
L44.3
ICD-10 Finland
Lichen ruber moniliformis
25.1
14.7
20
8
K02.0
ICD-10 Finland
Caries limited to enamel
1.4
14.7
620
4408
N05CF02
ATC
zolpidem; oral
1.4
14.5
967
7444
G04BD12
ATC
mirabegron; oral
1.5
14.5
561
3916
M79.1
ICD-10 Finland
Myalgia
1.4
14.4
660
4768
P01BA02
ATC
hydroxychloroquine; oral
1.5
14.3
480
3250
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.7
14.3
98
369
J01FA06
ATC
roxithromycin; oral
1.2
14.3
2323
20110
N76.6
ICD-10 Finland
Ulceration of vulva
4.0
14.3
57
145
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
4.9
14.3
46
95
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
14.2
2389
20756
R03BA01
ATC
beclometasone; inhalant
1.4
14.1
763
5680
SBA10
NOMESCO Finland
Measurement of excretion of saliva
3.0
14.0
80
267
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
14.0
737
5458
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.2
14.0
141
647
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.8
14.0
262
1521
R96
ICPC
Asthma
1.5
13.8
481
3282
L29.9
ICD-10 Finland
Pruritus, unspecified
2.2
13.7
137
627
L29.2
ICD-10 Finland
Pruritus vulvae
2.7
13.7
90
331
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
13.7
1658
13860
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
13.6
533
3730
L01
ICPC
Neck symptom/complaint
1.4
13.5
725
5386
A03
ICPC
Fever
1.4
13.5
701
5180
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
13.4
1333
10862
K07.60
ICD-10 Finland
Snapping jaw
1.8
13.4
239
1365
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.0
13.4
176
904
L93.0
ICD-10 Finland
Discoid lupus erythematosus
4.0
13.4
52
130
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.2
13.3
132
605
K05.1
ICD-10 Finland
Chronic gingivitis
1.6
13.3
358
2303
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
13.3
438
2956
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
13.1
908
7027
LFA00
NOMESCO Finland
Incision of vulva or perineum
7.9
13.0
29
37
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
6.5
13.0
33
51
J01FA15
ATC
telithromycin; oral
1.5
13.0
535
3779
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
12.9
559
3991
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.3
12.9
1001
7876
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
12.9
943
7355
D06BX01
ATC
metronidazole; topical
1.4
12.9
579
4161
F29
ICPC
Eye symptom/complaint other
1.5
12.9
422
2841
A01AB10
ATC
natamycin; local oral
2.0
12.9
155
770
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.5
12.8
399
2654
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
12.8
1012
7987
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.4
12.8
599
4343
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
12.7
298
1847
R05FB02
ATC
cough suppressants and expectorants
1.2
12.7
2192
19034
R42
ICD-10 Finland
Dizziness and giddiness
1.3
12.7
1195
9666
XQ845
NOMESCO Finland
Dermatoscopy
2.7
12.7
87
328
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
12.6
505
3548
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
12.6
1346
11059
H02AB07
ATC
prednisone; oral
1.4
12.6
779
5920
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
12.6
920
7178
R06AX13
ATC
loratadine; oral
1.4
12.5
771
5860
EKC00
NOMESCO Finland
Suture of cheek
10.0
12.4
24
24
B35.1
ICD-10 Finland
Tinea unguium
1.7
12.4
277
1695
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.5
12.3
504
3556
SXC03
NOMESCO Finland
Other oral or dental procedure
2.9
12.3
76
268
L57.0
ICD-10 Finland
Actinic keratosis
1.4
12.3
524
3727
K30
ICD-10 Finland
Functional dyspepsia
1.4
12.3
565
4079
N06AX21
ATC
duloxetine; oral
1.4
12.3
562
4055
N06AX16
ATC
venlafaxine; oral
1.4
12.2
671
4999
J01AA04
ATC
lymecycline; systemic
1.4
12.2
611
4482
A46
ICD-10 Finland
Erysipelas
1.4
12.2
699
5248
R09
ICPC
Sinus symptom/complaint
1.5
12.1
365
2414
E03
ICD-10 Finland
Other hypothyroidism
1.6
12.1
328
2117
KGH10
NOMESCO Finland
Operation for phimosis
2.3
12.0
107
466
M48.0
ICD-10 Finland
Spinal stenosis
1.4
12.0
668
4988
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.5
12.0
442
3050
S06
ICPC
Rash localized
1.6
12.0
297
1867
K03.00
ICD-10 Finland
Approximal wear
1.7
12.0
256
1548
KGB00
NOMESCO Finland
Biopsy of penis
11.0
12.0
22
20
N90.4
ICD-10 Finland
Leukoplakia of vulva
4.5
12.0
41
91
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.4
12.0
600
4401
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.3
11.9
791
6079
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.7
11.9
265
1624
E000003
ATC
NA
1.7
11.8
239
1422
S88
ICPC
Dermatitis contact/allergic
2.3
11.8
108
477
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
11.8
580
4241
N76.0
ICD-10 Finland
Acute vaginitis
1.8
11.8
210
1203
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.4
11.8
495
3515
A07EA06
ATC
budesonide; oral, local oral
1.8
11.8
182
997
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
11.7
1242
10182
N01
ICPC
Headache
1.5
11.6
427
2950
D01AC02
ATC
miconazole; topical
1.5
11.5
398
2713
A02BC04
ATC
rabeprazole; oral
1.5
11.5
448
3132
R21
ICPC
Throat symptom/complaint
1.3
11.5
862
6747
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.8
11.4
207
1192
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
2.8
11.4
72
260
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
11.3
718
5476
N06AA09
ATC
amitriptyline; systemic
1.4
11.3
564
4130
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
15.0
11.3
18
12
L50.3
ICD-10 Finland
Dermatographic urticaria
2.4
11.3
93
391
L44.1
ICD-10 Finland
Lichen nitidus
35.1
11.3
14
*
R03DC03
ATC
montelukast; oral
1.3
11.2
823
6418
G04CA02
ATC
tamsulosin; oral
1.3
11.2
872
6858
L28
ICPC
Limited function/disability (L)
1.3
11.1
817
6376
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
11.1
3856
35659
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
11.1
462
3275
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
11.0
968
7738
K13.7
ICD-10 Finland
Other and unspecified lesions of oral mucosa
5.0
11.0
34
68
L12
ICPC
Hand/finger symptom/complaint
1.3
11.0
712
5448
L73.8
ICD-10 Finland
Other specified follicular disorders
3.3
10.9
54
166
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
10.9
1426
11976
EBB10
NOMESCO Finland
Insertion of dental implant
2.5
10.9
82
330
F45.8
ICD-10 Finland
Other somatoform disorders
1.6
10.9
293
1886
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
10.9
2302
20320
104
Kela drug reimbursment
Thyroid insufficiency
1.5
10.8
427
2990
K11.70
ICD-10 Finland
Hypoptyalism
3.5
10.8
49
141
K08.80
ICD-10 Finland
Toothache NOS
1.5
10.8
371
2526
L02
ICPC
Back symptom/complaint
1.4
10.7
437
3081
J01CA08
ATC
pivmecillinam; oral
1.2
10.7
2288
20206
S01
ICPC
Pain/tenderness of skin
1.7
10.7
221
1325
J05AB11
ATC
valaciclovir; oral
1.3
10.6
680
5191
D07XB05
ATC
dexamethasone, combinations; topical
2.0
10.6
140
723
J01AA07
ATC
tetracycline; systemic
1.3
10.6
719
5541
M54.6
ICD-10 Finland
Pain in thoracic spine
1.5
10.6
328
2183
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.5
10.6
328
2184
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.7
10.6
204
1199
D11
ICPC
Diarrhoea
1.4
10.5
503
3655
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
6.0
10.5
28
47
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.0
10.5
128
640
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.5
10.5
339
2281
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.5
10.4
415
2915
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
10.4
492
3569
B86
ICD-10 Finland
Scabies
2.6
10.4
77
304
J01EA01
ATC
trimethoprim; systemic
1.2
10.4
1374
11548
WKPAL
NOMESCO Finland
NA
2.1
10.4
109
515
K13.03
ICD-10 Finland
Keilit UNS
5.6
10.4
29
52
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
10.4
1949
16993
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
10.3
836
6607
A04
ICPC
Weakness/tiredness general
1.4
10.3
621
4700
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
10.3
693
5336
L71.8
ICD-10 Finland
Other rosacea
2.5
10.3
78
316
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.5
10.3
358
2446
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.6
10.2
230
1417
D83
ICPC
Mouth/tongue/lip disease
4.2
10.1
37
89
UKC02
NOMESCO Finland
Cystoscopy
1.3
10.1
749
5848
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.1
10.1
116
570
D01
ICPC
Abdominal pain/cramps general
1.4
10.1
496
3627
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
10.0
313
2089
N05BA04
ATC
oxazepam; oral
1.2
10.0
1289
10797
PAD
NOMESCO Finland
NA
9.1
10.0
20
22
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.5
10.0
300
1983
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
10.0
1868
16262
B37.0
ICD-10 Finland
Candidal stomatitis
2.6
10.0
68
259
G03CA04
ATC
estriol; systemic, vaginal
1.4
10.0
410
2899
P03
ICPC
Feeling depressed
1.5
9.9
363
2505
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.8
9.9
180
1039
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
9.8
1155
9570
EAA10
NOMESCO Finland
Excision of lesion of lip
2.5
9.8
74
298
Z70.8
ICD-10 Finland
Other sex counselling
6.3
9.8
25
40
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
1.9
9.8
129
669
L12.0
ICD-10 Finland
Bullous pemphigoid
3.6
9.7
42
117
J45
ICD-10 Finland
Asthma
1.4
9.7
493
3622
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
9.7
987
8036
U02
ICPC
Urinary frequency/urgency
1.3
9.7
701
5451
N06AB04
ATC
citalopram; systemic
1.3
9.6
1130
9358
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
9.6
404
2868
K03.80
ICD-10 Finland
Irradiated enamel
1.6
9.6
214
1316
SPAT1058
SPAT
PEF monitoring instruction
1.4
9.6
442
3193
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.3
9.5
583
4421
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
9.1
9.5
19
21
K14.60
ICD-10 Finland
Glossopyrosis
3.5
9.5
42
120
N05CF01
ATC
zopiclone; oral
1.2
9.5
1748
15185
R07.0
ICD-10 Finland
Pain in throat
1.6
9.4
268
1751
M79.7
ICD-10 Finland
Fibromyalgia
1.8
9.4
167
959
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.4
9.4
373
2619
R03AC03
ATC
terbutaline; inhalant
1.3
9.4
713
5583
EKB00
NOMESCO Finland
Excision of lesion of cheek
3.9
9.4
37
96
SPAT1097
SPAT
Recording of ECG
1.3
9.3
795
6326
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.4
9.3
375
2638
E000004
ATC
NA
2.0
9.3
108
532
Z00.0
ICD-10 Finland
General medical examination
1.3
9.3
920
7459
R60.0
ICD-10 Finland
Localized oedema
1.4
9.3
561
4245
-
ICD-10 Finland
NA
1.9
9.3
125
653
UJH02
NOMESCO Finland
Anoscopy
1.6
9.2
213
1319
R03BA02
ATC
budesonide; inhalant
1.3
9.2
901
7296
A01
ICPC
Pain general/multiple sites
1.4
9.2
379
2683
R06.5
ICD-10 Finland
Mouth breathing
1.4
9.2
398
2844
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.3
9.1
569
4325
H01
ICPC
Ear pain/earache
1.4
9.1
484
3586
L20.8
ICD-10 Finland
Other atopic dermatitis
2.8
9.1
58
212
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
9.1
404
2897
K05.18
ICD-10 Finland
Chronic gingivitis
1.6
9.1
230
1461
L82
ICD-10 Finland
Seborrhoeic keratosis
1.3
9.1
828
6643
D01AE15
ATC
terbinafine; topical
1.5
9.1
335
2317
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.3
9.1
601
4616
N06AX26
ATC
vortioxetine; oral
1.6
9.0
226
1432
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.4
9.0
429
3119
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
9.0
283
1891
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
9.0
527
3968
L44.2
ICD-10 Finland
Lichen striatus
36.7
9.0
11
*
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
9.0
768
6109
R03BA08
ATC
ciclesonide; inhalant
1.4
9.0
412
2974
L40.8
ICD-10 Finland
Other psoriasis
3.0
9.0
49
164
SPAT1240
SPAT
Therapeutic discussion
1.4
9.0
447
3279
L29.0
ICD-10 Finland
Pruritus ani
2.9
8.9
52
180
A11
ICPC
Chest pain NOS
1.4
8.9
381
2717
A03FA02
ATC
cisapride; oral, rectal
1.4
8.9
401
2889
H60.8
ICD-10 Finland
Other otitis externa
1.8
8.8
136
749
P06
ICPC
Sleep disturbance
1.4
8.8
442
3243
H92.0
ICD-10 Finland
Otalgia
1.6
8.8
233
1498
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
8.8
526
3975
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.3
8.8
553
4210
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.8
8.8
143
803
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.6
8.7
246
1605
R02
ICPC
Shortness of breath/dyspnoea
1.3
8.7
600
4632
L28.2
ICD-10 Finland
Other prurigo
4.0
8.7
33
83
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
2.0
8.7
106
537
K14.61
ICD-10 Finland
Glossodynia
2.8
8.7
55
201
L50.9
ICD-10 Finland
Urticaria, unspecified
1.7
8.6
156
901
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.2
8.6
81
367
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.5
8.6
314
2172
L14
ICPC
Leg/thigh symptom/complaint
1.4
8.5
367
2619
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
3.6
8.4
36
101
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
4.7
8.4
27
58
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.6
8.4
185
1135
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.5
8.4
268
1802
F51.0
ICD-10 Finland
Nonorganic insomnia
1.3
8.4
583
4508
N06AB10
ATC
escitalopram; oral
1.3
8.3
912
7485
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
8.3
245
1618
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.4
8.3
352
2508
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
1.4
8.3
487
3668
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
8.3
421
3096
S76
ICPC
Skin infection other
1.5
8.3
238
1559
A07EC02
ATC
mesalazine; oral, rectal
1.5
8.3
255
1702
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
1.9
8.3
111
582
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.5
8.3
268
1806
K29.4
ICD-10 Finland
Chronic atrophic gastritis
1.9
8.3
111
583
R35
ICD-10 Finland
Polyuria
1.5
8.2
278
1889
K05.12
ICD-10 Finland
Gingivitis (chronic) simple marginal
7.1
8.2
19
27
L42
ICD-10 Finland
Pityriasis rosea
4.0
8.2
31
78
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
1.5
8.2
240
1580
M54.2
ICD-10 Finland
Cervicalgia
1.4
8.2
336
2378
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.9
8.2
120
648
M13.9
ICD-10 Finland
Arthritis, unspecified
1.4
8.2
336
2381
K04.08
ICD-10 Finland
Other specified pulpit
1.5
8.1
253
1691
L29.8
ICD-10 Finland
Other pruritus
2.4
8.1
63
259
M01AX01
ATC
nabumetone; oral
1.5
8.1
242
1601
A07EC01
ATC
sulfasalazine; oral, rectal
1.4
8.1
398
2914
U07
ICPC
Urine symptom/complaint other
1.5
8.1
285
1957
J01MA12
ATC
levofloxacin; systemic
1.2
8.1
921
7595
H10
ICD-10 Finland
Conjunctivitis
1.5
8.1
263
1777
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.3
8.0
523
4003
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.3
8.0
615
4819
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
8.0
519
3971
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.4
8.0
328
2324
H29
ICPC
Ear symptom/complaint other
1.3
7.9
501
3819
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.3
7.9
577
4488
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.3
7.9
471
3555
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.7
7.9
167
1012
C10AX09
ATC
ezetimibe; oral
1.3
7.9
559
4330
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.5
7.9
224
1467
J33.0
ICD-10 Finland
Polyp of nasal cavity
1.8
7.8
125
697
SPAT1336
SPAT
Request for examination
1.6
7.8
181
1127
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
8.4
7.8
16
19
N17
ICPC
Vertigo/dizziness
1.3
7.8
553
4290
SPAT1211
SPAT
Application of soft bandage
1.4
7.8
428
3190
EJB40
NOMESCO Finland
Hemiglossectomy
6.9
7.8
18
26
K60.1
ICD-10 Finland
Chronic anal fissure
1.9
7.7
107
569
N76.8
ICD-10 Finland
Other specified inflammation of vagina and vulva
2.5
7.7
58
236
Y04
ICPC
Penis symptom/complaint other
4.0
7.7
29
73
8070/3-C03.1
ICD-O-3
Squamous cell carcinoma, NOS, of lower gum
15.0
7.7
12
8
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.3
7.7
547
4249
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
2.5
7.6
54
213
XKD00
NOMESCO Finland
Uroflowmetry
1.3
7.6
641
5087
K13
ICD-10 Finland
Other diseases of lip and oral mucosa
4.7
7.6
24
51
ZXA05
NOMESCO Finland
Left side
1.2
7.6
1380
11934
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
7.6
665
5308
N06AB03
ATC
fluoxetine; oral
1.3
7.6
626
4960
M54
ICD-10 Finland
Dorsalgia
1.3
7.5
525
4063
C10AC01
ATC
colestyramine; oral
1.7
7.5
134
776
K13.1
ICD-10 Finland
Cheek and lip biting
3.3
7.5
36
111
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
7.5
936
7788
LEA10
NOMESCO Finland
Colpotomy
10.0
7.5
14
14
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.5
1373
11880
M01AH02
ATC
rofecoxib; oral
1.3
7.5
709
5716
L28
ICD-10 Finland
Lichen simplex chronicus and prurigo
2.7
7.5
49
185
B81
ICPC
Anaemia vit B12/folate deficiency
1.6
7.5
171
1061
K14.1
ICD-10 Finland
Geographic tongue
3.1
7.5
39
128
N81.6
ICD-10 Finland
Rectocele
1.4
7.5
370
2714
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
2.1
7.4
81
394
XKC03
NOMESCO Finland
Water cystometry
1.6
7.4
162
992
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
7.4
252
1717
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
7.4
621
4928
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.0
7.4
87
435
B03BA03
ATC
hydroxocobalamin; parenteral
1.5
7.4
256
1752
EDB00
NOMESCO Finland
Partial excision of mandible
5.0
7.4
22
44
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.4
7.4
427
3211
ECA30
NOMESCO Finland
Excision of lesion of gingiva
2.3
7.4
64
279
L71.0
ICD-10 Finland
Perioral dermatitis
2.3
7.4
64
279
R29
ICPC
Respiratory symptom/complaint other
1.5
7.4
279
1948
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
7.4
609
4824
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.2
7.4
854
7050
J01MA06
ATC
norfloxacin; oral
1.3
7.4
710
5735
K05.08
ICD-10 Finland
Another acute gingivitis
1.9
7.3
107
578
M54.8
ICD-10 Finland
Other dorsalgia
1.6
7.3
187
1194
D07CB01
ATC
triamcinolone and antibiotics; topical
1.8
7.3
109
594
B37
ICD-10 Finland
Candidiasis
4.7
7.3
23
49
ZXC10
NOMESCO Finland
Use of laser
1.9
7.3
107
581
M45
ICD-10 Finland
Ankylosing spondylitis
1.9
7.3
95
496
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
7.3
529
4116
R83
ICPC
Respiratory infection other
1.2
7.3
997
8383
ZY010
NOMESCO Finland
Hospital outpatient
1.6
7.2
183
1165
K14.9
ICD-10 Finland
Disease of tongue, unspecified
4.0
7.2
27
68
R15
ICD-10 Finland
Faecal incontinence
1.7
7.2
138
816
C07AA05
ATC
propranolol; systemic
1.2
7.2
951
7963
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.4
7.2
328
2371
Z71.8
ICD-10 Finland
Other specified counselling
1.2
7.2
1155
9866
K02.2
ICD-10 Finland
Caries of cementum
1.5
7.2
204
1338
QBA
NOMESCO Finland
Incision or local destruction of lesion of skin of trunk
20.0
7.1
10
5
P20
ICPC
Memory disturbance
1.3
7.1
565
4455
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.4
7.1
391
2921
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.4
7.1
325
2354
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.3
7.1
481
3708
A63.0
ICD-10 Finland
Anogenital (venereal) warts
1.8
7.0
122
701
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.3
7.0
459
3519
WX110
SPAT
NA
1.5
7.0
195
1274
A02BA04
ATC
nizatidine; systemic
1.4
7.0
386
2879
H13
ICPC
Plugged feeling ear
1.2
7.0
883
7356
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.3
7.0
475
3660
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.4
7.0
285
2017
N48.5
ICD-10 Finland
Ulcer of penis
7.0
7.0
16
23
N06AA12
ATC
doxepin; systemic
1.4
7.0
264
1844
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
7.0
677
5477
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.3
7.0
406
3058
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.6
7.0
172
1091
L40.4
ICD-10 Finland
Guttate psoriasis
3.7
6.9
28
76
X16
ICPC
Vulval symptom/complaint
2.4
6.9
56
238
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
1.5
6.9
246
1696
R01AD05
ATC
budesonide; nasal
1.4
6.9
370
2748
T78.3
ICD-10 Finland
Angioneurotic oedema
2.2
6.9
69
322
SPAT1081
SPAT
Cardiorespiratory global assessment
1.4
6.9
281
1988
J33.8
ICD-10 Finland
Other polyp of sinus
1.9
6.9
96
514
G03CB01
ATC
dienestrol; oral, vaginal
1.7
6.9
145
882
M77.1
ICD-10 Finland
Lateral epicondylitis
1.4
6.9
303
2176
L04AX01
ATC
azathioprine; systemic
1.5
6.9
204
1354
TQW99
NOMESCO Finland
Other minor procedure on skin
1.5
6.9
232
1580
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.3
6.9
411
3108
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
6.9
210
1404
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
2.8
6.9
40
141
A60
ICPC
General and Unspecified, Result test/procedure
1.5
6.8
205
1363
ZXD20
NOMESCO Finland
Day surgery
1.3
6.8
638
5136
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
3.1
6.8
34
109
M01AH03
ATC
valdecoxib; oral
1.4
6.8
320
2325
K10.3
ICD-10 Finland
Alveolitis of jaws
1.6
6.8
180
1164
D02
ICPC
Abdominal pain epigastric
1.4
6.8
274
1939
K07
ICPC
Swollen ankles/oedema
1.5
6.8
207
1382
K59.0
ICD-10 Finland
Constipation
1.5
6.8
251
1747
G03CC04
ATC
estrone; systemic
1.6
6.7
176
1130
K14.69
ICD-10 Finland
Tongue pain UNS
3.2
6.7
32
99
D01AE16
ATC
amorolfine; topical
1.3
6.7
590
4710
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
6.7
379
2841
L92.0
ICD-10 Finland
Granuloma annulare
3.3
6.7
31
94
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
2.1
6.7
73
356
R49.08
ICD-10 Finland
Other specified dysphonia
1.8
6.7
102
562
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
1.9
6.7
88
461
R39.1
ICD-10 Finland
Other difficulties with micturition
1.7
6.7
122
712
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
2.2
6.7
63
290
D06BB03
ATC
aciclovir; topical
1.5
6.6
242
1679
WX720
NOMESCO Finland
Own respiration
1.6
6.6
173
1113
L12.8
ICD-10 Finland
Other pemphigoid
7.8
6.6
14
18
N05BA01
ATC
diazepam; systemic, rectal
1.3
6.6
648
5247
N39.3
ICD-10 Finland
Stress incontinence
1.3
6.6
387
2923
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
2.8
6.6
39
140
K12
ICD-10 Finland
Stomatitis and related lesions
4.6
6.6
21
46
M77.4
ICD-10 Finland
Metatarsalgia
1.4
6.6
250
1750
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.2
6.5
714
5855
C10AA04
ATC
fluvastatin; oral
1.3
6.5
424
3250
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.5
6.5
188
1240
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.3
6.5
592
4745
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
2.2
6.5
61
277
SPAT1192
SPAT
Gynaecological examination
1.4
6.5
273
1946
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
1.5
6.5
223
1531
L16
ICPC
Ankle symptom/complaint
1.3
6.5
466
3627
R53
ICD-10 Finland
Malaise and fatigue
1.2
6.5
950
8039
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
3.7
6.4
26
71
G04CB02
ATC
dutasteride; oral
1.5
6.4
209
1415
S01.50
ICD-10 Finland
Open wound in oral cavity
2.4
6.4
50
210
K95
ICPC
Varicose veins of leg
2.0
6.4
75
376
I84.5
ICD-10 Finland
External hemorrhoids without complication
1.6
6.4
152
957
WX002
NOMESCO Finland
Sedation and analgesia
1.2
6.4
1033
8820
R30.1
ICD-10 Finland
Vesical tenesmus
1.9
6.4
82
428
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
14.3
6.4
10
7
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.4
6.4
347
2590
H01.0
ICD-10 Finland
Blepharitis
1.5
6.3
237
1652
K14.5
ICD-10 Finland
Plicated tongue
4.9
6.3
19
39
B48.8
ICD-10 Finland
Other specified mycoses
6.5
6.3
15
23
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.3
6.3
462
3604
J34.2
ICD-10 Finland
Deviated nasal septum
1.5
6.3
218
1498
S15
ICPC
Foreign body in skin
1.4
6.3
295
2144
XJH00
NOMESCO Finland
Transanal ultrasonography
1.5
6.3
222
1528
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.6
6.3
149
937
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.4
6.3
346
2587
H02.3
ICD-10 Finland
Blepharochalasis
1.4
6.3
315
2316
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
1.8
6.3
100
560
U05
ICPC
Urination problems other
1.5
6.3
195
1308
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.5
6.2
226
1567
I10
ICD-10 Finland
Essential (primary) hypertension
1.1
6.2
3331
31172
EB1AA
SPAT
NA
1.5
6.2
201
1362
H00.1
ICD-10 Finland
Chalazion
1.6
6.2
150
949
SPAT1283
SPAT
Restricted health certificate
1.3
6.2
616
4998
X15
ICPC
Vaginal symptom/complaint other
1.7
6.2
123
738
F41.00
ICD-10 Finland
Moderate panic disorder
2.1
6.2
62
293
J01FA01
ATC
erythromycin; systemic
1.3
6.2
617
5008
M67.4
ICD-10 Finland
Ganglion
1.4
6.2
288
2094
N94.1
ICD-10 Finland
Dyspareunia
2.5
6.2
44
175
UDC00
NOMESCO Finland
Ear microscopy
1.4
6.2
328
2438
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.4
6.1
257
1830
D11AH01
ATC
tacrolimus; topical
2.7
6.1
40
151
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.4
6.1
279
2020
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
7.7
6.1
13
17
ZXA00
NOMESCO Finland
Right side
1.2
6.1
1462
12919
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
12.5
6.1
10
8
M19.8
ICD-10 Finland
Other specified arthrosis
1.5
6.1
170
1113
XQ899
NOMESCO Finland
Other assessment of skin
3.3
6.0
28
86
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.5
6.0
170
1118
R06.2
ICD-10 Finland
Wheezing
1.5
6.0
188
1263
EJ2S1
SPAT
NA
10.0
6.0
11
11
R52.2
ICD-10 Finland
Other chronic pain
1.6
6.0
157
1012

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
1077
2878
4.20
307.65
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
460
891
5.44
225.75
2.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1377
7566
2.01
106.14
1.7
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
3531
26657
1.62
86.48
2.4
2.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
206
486
4.33
79.23
1.5
1.5
u/ml
20.0
20.3
0.03
49
106
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
183
401
4.65
77.26
1.3
1.3
titre
52.1
58.8
0.15
19
32
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
185
421
4.48
74.51
1.3
1.3
titre
350.0
364.7
—
9
36
(3013707) Erythrocyte sedimentation rate by Westergren method
5553
47793
1.63
70.87
4.7
4.2
mm/h
12.4
12.9
1.80
5144
44141
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5639
49534
1.57
57.66
4.7
4.2
pmol/l
14.9
14.9
0.18
5113
44892
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1919
13568
1.56
55.82
1.3
1.2
u/ml
1.5
1.7
0.26
525
3515
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6440
58595
1.72
55.40
5.8
5.0
mu/l
2.3
2.1
0.27
5908
53488
(3037522) Nuclear Ab [Titer] in Serum
1299
8622
1.61
48.65
1.4
1.3
titre
529.0
538.0
0.06
289
1883
(3037467) Urinalysis macro (dipstick) panel - Urine
5048
43944
1.46
48.17
5.1
4.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
3929
32853
1.41
45.51
6.4
6.0
e9/l
0.2
0.2
2.93
3461
28636
(3006315) Basophils [#/volume] in Blood
3818
31788
1.41
45.19
6.2
5.9
e9/l
0.0
0.0
1.54
3335
27242
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6769
63133
1.78
44.65
15.7
14.6
mg/l
21.4
23.6
6.56
5473
50196
(3031040) Bacteria [#/volume] in Urine by Automated count
4851
42238
1.42
43.73
5.2
4.6
e6/l
263.1
2084.8
5.40
47
579
(3001604) Monocytes [#/volume] in Blood
3784
31649
1.40
42.50
6.2
5.8
e9/l
0.6
0.6
2.47
3303
27120
(3007164) IgA [Mass/volume] in Serum or Plasma
1636
11772
1.50
41.89
1.4
1.5
g/l
2.5
2.5
0.08
969
6921
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5593
50140
1.46
41.86
7.9
7.7
u/l
77.2
78.6
1.49
5273
47122
(3019198) Lymphocytes [#/volume] in Blood
3860
32498
1.39
41.09
6.2
5.9
e9/l
1.9
1.9
1.24
3397
28398
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3290
27045
1.39
40.08
2.1
2.0
pmol/l
96.4
96.8
0.14
1641
13534
(3023103) Potassium [Moles/volume] in Serum or Plasma
6961
65924
1.83
37.27
17.9
16.9
mmol/l
4.0
4.0
0.23
6797
64227
(3019550) Sodium [Moles/volume] in Serum or Plasma
6948
65764
1.82
37.27
17.8
16.8
mmol/l
139.7
139.7
0.51
6795
64184
(3013650) Neutrophils [#/volume] in Blood by Automated count
4279
37018
1.37
36.40
8.9
9.3
e9/l
3.9
4.1
6.29
3777
32194
(3048689) Calprotectin [Mass/mass] in Stool
1100
7469
1.55
36.37
2.4
2.2
ug/g
142.6
141.6
0.03
862
5831
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
6381
59193
1.54
36.24
6.5
5.9
mmol/mol
40.0
39.9
0.28
5893
54522
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1526
11243
1.45
33.60
1.3
1.3
iu/ml
31.0
35.6
0.82
478
3557
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
6688
62936
1.60
33.08
5.1
4.5
mmol/l
4.7
4.7
4.72
6193
57954
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7057
67409
1.87
32.52
12.2
10.8
u/l
25.9
25.9
0.02
6828
64926
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
6790
64219
1.64
31.83
5.6
5.1
mmol/l
2.7
2.8
2.34
6244
58843
(3021601) Nitrite [Presence] in Urine by Test strip
3660
31320
1.33
31.27
5.6
5.1
estimate
0.0
0.0
0.35
636
5731
(3009261) Glucose [Presence] in Urine by Test strip
3691
31662
1.33
30.82
4.3
3.8
estimate
0.0
0.0
2.19
609
5641
(3035350) Ketones [Presence] in Urine by Test strip
3642
31186
1.33
30.78
4.2
3.8
estimate
0.0
0.0
0.80
620
5669
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2515
20413
1.35
30.59
2.6
2.6
u/l
56.0
57.7
1.20
2291
18760
(3006504) Eosinophils/100 leukocytes in Blood
3483
29656
1.33
30.53
6.5
6.1
%
3.0
2.9
4.86
3241
27502
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
6631
62464
1.55
30.48
5.0
4.5
mmol/l
1.5
1.5
3.66
6099
57166
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
6601
62135
1.54
30.28
5.2
4.7
mmol/l
6.0
6.0
0.58
6032
56438
(3022096) Basophils/100 leukocytes in Blood
3389
28797
1.32
29.89
6.5
6.1
%
0.7
0.7
3.46
3157
26736
(3019069) Monocytes/100 leukocytes in Blood
3495
29829
1.32
29.87
6.8
6.4
%
8.7
8.6
0.19
3261
27804
(3005322) IgE [Units/volume] in Serum or Plasma
603
3709
1.68
29.66
1.3
1.3
u/ml
292.8
194.5
1.43
552
3396
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3241
27411
1.32
29.35
2.4
2.3
nmol/l
78.7
78.9
0.11
2890
24528
(3018010) Neutrophils/100 leukocytes in Blood
3520
30118
1.32
29.35
6.3
6.0
%
56.8
57.3
1.60
3273
28008
(3007853) Bacteria identified in Skin by Aerobe culture
1051
7372
1.50
29.35
1.8
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1431
10648
1.43
29.34
1.3
1.3
u/ml
13.3
13.9
0.06
544
4054
(3024561) Albumin [Mass/volume] in Serum or Plasma
3337
28364
1.32
29.06
4.7
4.7
g/l
35.7
35.4
2.75
3106
26276
(3020564) Creatinine [Moles/volume] in Serum or Plasma
7030
67296
1.77
28.99
18.4
17.2
umol/l
75.5
76.1
0.95
7025
67276
(3002030) Lymphocytes/100 leukocytes in Blood
3557
30537
1.31
28.69
6.6
6.2
%
28.1
27.8
0.67
3296
28289
(3007461) Platelets [#/volume] in Blood
7217
69691
2.09
28.61
23.9
21.6
e9/l
249.6
252.5
3.40
7037
67854
(3024731) MCV [Entitic volume]
7218
69720
2.08
28.34
23.8
21.6
fl
91.2
91.2
0.71
7122
68702
(3026361) Erythrocytes [#/volume] in Blood
7218
69727
2.08
28.22
23.9
21.6
e12/l
4.5
4.5
2.73
7020
67687
(3000963) Hemoglobin [Mass/volume] in Blood
7218
69741
2.07
27.97
24.0
21.7
g/l
135.2
134.5
4.35
7123
68741
(3035941) MCH [Entitic mass]
7216
69718
2.07
27.92
23.8
21.5
pg
30.3
30.3
0.56
7121
68697
(3010813) Leukocytes [#/volume] in Blood
7217
69743
2.06
27.71
23.9
21.7
e9/l
6.6
6.7
2.39
7014
67691
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1383
10323
1.42
27.67
1.5
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3890
33998
1.30
26.66
5.8
6.3
umol/l
10.9
11.1
0.32
3680
32229
(3015171) Extractable nuclear Ab [Units/volume] in Serum
438
2546
1.77
26.38
1.3
1.3
u/ml
1.7
1.0
0.34
33
248
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3795
33108
1.30
26.14
6.1
6.6
mmol/l
1.2
1.2
0.09
3212
27861
(3021960) Folate [Moles/volume] in Serum or Plasma
1910
15151
1.35
26.12
1.6
1.5
nmol/l
21.5
20.9
0.89
1634
12865
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6399
60263
1.43
25.15
4.5
4.0
mmol/l
1.3
1.3
0.92
5849
54679
(42870588) Differential panel, method unspecified - Blood
2619
21840
1.31
24.99
6.3
5.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3052
25999
1.29
24.71
2.9
2.8
ug/l
125.5
132.9
0.80
2793
23921
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4136
36638
1.29
24.66
2.8
2.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1126
8266
1.43
24.44
7.0
7.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1237
9283
1.40
23.59
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
4227
37729
1.28
22.88
4.5
4.6
mmol/l
6.7
6.7
1.01
3961
35328
(4010399)
702
4788
1.51
22.11
1.5
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
6824
65368
1.51
21.62
15.3
13.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
143
595
2.43
21.52
1.3
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
325
1841
1.80
21.37
1.3
1.3
u/ml
16.0
40.0
1.36
16
112
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2391
20017
1.29
21.23
2.2
2.1
u/l
157.3
212.3
3.86
2224
18709
(3019150) Specific gravity of Urine by Refractometry
1702
13627
1.32
21.07
4.7
4.3
kg/l
1.0
1.0
0.09
248
2066
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1931
15744
1.31
20.93
2.3
2.3
mg/l
2.9
3.0
1.15
1630
13472
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3423
30018
1.26
20.47
5.2
5.9
mmol/l
1.2
1.2
0.42
3068
27081
(3000570) Elastase.pancreatic [Mass/mass] in Stool
347
2031
1.74
20.40
1.4
1.4
ug/g
272.0
276.0
0.14
202
1177
(36660697) Celiac disease serology panel - Serum
710
4941
1.48
20.21
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
525
3438
1.57
19.86
1.3
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
65
183
3.57
19.78
1.9
1.5
ug/l
9.5
8.7
0.70
65
183
(3011397) Hemoglobin [Presence] in Urine by Test strip
1856
15149
1.30
19.75
4.3
3.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4495
40777
1.26
19.65
3.4
3.1
u/l
48.6
49.5
0.27
4143
37718
(3026008) Bacteria identified in Urine by Culture
2424
20531
1.27
19.08
3.6
3.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
252
1388
1.84
18.20
1.3
1.2
u/ml
5.3
5.5
0.02
24
96
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
315
1859
1.73
18.00
1.6
1.6
g/l
0.2
0.2
0.52
298
1755
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2753
23819
1.25
17.64
4.6
4.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2835
24615
1.24
17.58
3.8
3.6
ng/l
60.4
65.2
0.05
1940
17160
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
293
1706
1.75
17.58
1.3
1.3
u/ml
2.9
6.7
2.28
46
271
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2250
19040
1.26
17.48
2.9
2.9
ng/l
1169.7
1348.8
0.98
1902
16356
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
320
1914
1.70
17.43
1.6
1.6
g/l
1.2
1.2
0.00
304
1807
(3019309) Folate [Moles/volume] in Red Blood Cells
1517
12247
1.30
17.17
1.7
1.8
nmol/l
1160.7
1169.9
0.15
1128
9218
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
243
1361
1.81
16.65
1.3
1.2
u/ml
39.8
43.5
0.15
33
155
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
287
1688
1.73
16.63
1.3
1.3
u/ml
5.5
4.7
0.12
28
173
(3013139) Helicobacter pylori Ag [Presence] in Stool
625
4426
1.45
16.18
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
735
5372
1.41
15.97
3.7
3.6
—
—
—
0
0
(3044889) 12 lead EKG panel
4919
45555
1.23
15.74
4.1
3.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1202
9517
1.31
15.55
1.5
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1996
16845
1.25
15.48
4.7
4.3
estimate
0.0
0.0
0.11
620
5556
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2386
20607
1.23
14.84
3.2
3.3
u/l
33.8
35.1
0.30
2241
19492
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
568
4069
1.43
13.78
1.2
1.2
iu/ml
131.1
145.3
0.42
206
1518
(3012516) Albumin [Mass/volume] in Urine
2245
19401
1.22
13.61
3.4
3.2
mg/l
619.9
403.5
0.95
1352
11818
(3032080) INR in Blood by Coagulation assay
2964
26332
1.21
13.56
9.0
8.8
inr
1.2
1.2
0.56
812
7435
(3042936) Bacteria identified in Isolate by Culture
1120
8947
1.30
13.40
2.0
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
512
3624
1.44
13.26
1.9
1.8
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
406
2751
1.50
13.13
1.1
1.1
titre
137.9
203.2
0.33
14
59
(3036481) Cortisol [Moles/volume] in Serum or Plasma
767
5832
1.35
12.99
2.4
2.2
nmol/l
367.4
374.7
0.48
683
5336
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2044
17568
1.23
12.93
1.7
1.6
mmol/l
1.4
1.4
0.04
1746
14619
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1673
14087
1.24
12.84
1.7
1.7
mg/l
1.1
1.2
1.08
1273
10822
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
562
4074
1.41
12.75
2.0
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
645
4787
1.38
12.73
1.6
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2568
22601
1.21
12.73
3.1
3.4
mmol/l
2.4
2.4
0.31
2194
19574
(3009508) Creatinine [Moles/volume] in Urine
2323
20260
1.21
12.63
3.3
3.2
mmol/l
7.0
7.2
0.76
1946
16886
(40760892) CBC W Ordered Manual Differential panel - Blood
1623
13643
1.24
12.62
4.7
4.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1659
13984
1.24
12.57
1.6
1.7
pmol/l
72857586.8
27812481.1
1.39
1330
11513
(3020682) Albumin/Creatinine [Ratio] in Urine
2334
20379
1.21
12.52
4.1
4.0
mg/mmol
8.2
9.1
0.42
1410
12434
(3022145) Colonoscopy Study observation
939
7398
1.31
12.41
1.3
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
6273
60169
1.27
12.17
14.4
13.7
ml/min/173m2
79.4
79.1
0.63
5242
49731
(3017143) Hepatitis C virus Ab [Presence] in Serum
797
6158
1.33
12.09
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
303
1965
1.56
12.01
1.6
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
349
2364
1.50
11.34
1.5
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
496
3602
1.40
11.15
2.5
2.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
793
6213
1.31
10.86
2.2
2.2
g/l
0.2
0.2
0.23
734
5795
(3039162) Centromere protein B Ab [Units/volume] in Serum
149
823
1.83
10.83
1.3
1.3
u/ml
39.4
59.6
0.72
18
59
(3003327) Ova and parasites identified in Stool by Light microscopy
299
1999
1.52
10.37
1.7
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3289
29957
1.18
10.34
4.1
4.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
2251
19860
1.19
10.33
3.5
4.1
ph
7.4
7.4
0.18
373
3781
(3023420) DNA double strand Ab [Units/volume] in Serum
127
680
1.88
10.21
1.5
1.4
iu/ml
24.6
22.4
—
7
31
(3009445) Proteinase 3 Ab [Units/volume] in Serum
388
2746
1.44
10.09
1.5
1.6
u/ml
8.1
17.6
—
8
77
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1496
12727
1.22
10.08
3.8
3.7
ng/l
365.8
430.8
0.22
1103
10038
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
721
5635
1.31
10.04
2.6
2.8
ng/l
185.2
187.0
0.03
661
5133
(3009542) Hematocrit [Volume Fraction] of Blood
5902
56517
1.21
9.98
17.0
15.8
%
39.8
39.5
1.98
3861
39377
(3013512) EKG study
2189
19326
1.19
9.87
4.4
3.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
531
3982
1.36
9.82
1.3
1.3
au/ml
60.7
54.3
—
9
178
(3020717) Zinc [Moles/volume] in Serum or Plasma
70
306
2.30
9.67
1.3
1.4
umol/l
20.3
26.7
1.13
70
288
(3026493) Urate [Moles/volume] in Serum or Plasma
1924
16864
1.19
9.33
2.7
2.6
umol/l
2420.0
4808.7
2.96
1662
14483
(3005719) IgG [Mass/volume] in Serum or Plasma
613
4733
1.32
9.32
2.6
2.8
g/l
10.8
10.5
0.72
570
4319
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1828
15961
1.19
9.24
5.0
4.9
ug/l
2.1
3.3
2.50
1633
14329
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
52
203
2.57
9.19
1.8
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
590
4542
1.32
9.16
2.2
2.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1187
9964
1.23
9.04
2.4
2.5
umol/l
13.0
12.8
0.30
1095
9216
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
570
4376
1.33
9.02
2.5
2.4
au/ml
22.8
24.8
0.09
16
209
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
311
2167
1.45
8.83
1.6
1.6
titre
416.7
296.5
0.24
12
108
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1226
10350
1.22
8.81
1.9
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1297
11031
1.21
8.63
2.9
2.7
e6/l
0.8
1.5
1.88
776
6248
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
417
3086
1.37
8.41
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1023
8533
1.23
8.23
24.3
24.6
inr
1.3
1.3
0.41
167
1242
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1096
9208
1.22
8.23
2.4
2.5
g/l
2.4
2.3
1.01
1009
8505
(3028026) IgM [Mass/volume] in Serum or Plasma
486
3708
1.33
8.04
1.6
1.9
g/l
1.4
1.4
0.02
447
3367
(3021589) Normoblasts [#/volume] in Blood
3060
28087
1.15
7.93
10.2
9.7
e9/l
0.0
0.0
0.05
2533
22902
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
253
1732
1.48
7.91
1.3
1.4
iu/ml
25.4
17.5
—
6
43
(3018095) Leukocytes [#/volume] in Urine
2500
22622
1.16
7.88
4.0
3.7
e6/l
97.2
107.6
0.24
1795
15843
(3004616) Nuclear Ab [Presence] in Serum
136
812
1.69
7.68
1.3
1.3
—
—
—
0
0
(3019225) pH of Specimen
823
6755
1.25
7.68
4.1
4.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1428
12391
1.19
7.56
2.9
3.0
mmol/l
2.5
2.5
1.78
1254
10840
(3030467) Casts [#/volume] in Urine by Automated count
1995
17795
1.17
7.54
3.3
3.1
e6/l
0.3
0.4
4.19
1513
13288
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
694
5598
1.26
7.53
2.2
2.3
ug/l
5.8
7.4
1.77
588
4866
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
239
1636
1.48
7.49
1.1
1.1
u/ml
8.9
6.8
0.21
24
162
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
96
522
1.85
7.48
1.2
1.2
u/ml
75.4
64.5
—
5
26
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
310
2229
1.41
7.46
1.4
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
1853
16449
1.17
7.43
6.6
6.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
461
3537
1.32
7.36
2.2
2.2
nmol/l
12.3
12.7
0.49
401
3101
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
96
525
1.84
7.35
1.2
1.2
u/ml
62.1
31.9
0.70
12
41
(44813793)
80
412
1.95
7.35
1.1
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
92
499
1.85
7.24
1.2
1.2
u/ml
2.7
4.1
—
6
31
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
22
60
3.67
7.17
1.0
1.2
u/ml
1.3
0.0
0.48
13
37
(3002582) Erythrocytes [#/volume] in Urine
2141
19279
1.16
7.04
3.4
3.2
e6/l
48.4
75.1
1.67
1650
14665
(3025130) Human papilloma virus identified in Specimen
131
794
1.66
7.03
1.8
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
297
2145
1.40
6.99
1.9
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
983
8306
1.21
6.91
1.7
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
88
478
1.85
6.91
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
88
478
1.85
6.91
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
88
479
1.85
6.87
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
243
1699
1.44
6.86
1.8
1.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
5474
52577
1.15
6.78
20.9
19.0
g/l
332.3
331.8
4.98
5439
52219
(40759836) Histone Ab [Presence] in Serum by Immunoblot
87
474
1.85
6.77
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
87
475
1.84
6.73
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
87
475
1.84
6.73
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
667
5443
1.25
6.55
2.4
2.6
g/l
67.1
66.4
1.78
607
4937
(3034770) Mitochondria Ab [Titer] in Serum
247
1748
1.43
6.55
1.3
1.2
titre
1019.1
945.1
0.08
11
63
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
23
69
3.34
6.54
1.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
510
4035
1.28
6.50
5.9
7.1
mmol/l
24.4
24.7
0.77
474
3755
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
850
7124
1.22
6.49
1.8
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
377
2875
1.33
6.32
1.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
246
1755
1.42
6.26
1.3
1.2
titre
109.6
152.2
0.44
24
155
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
849
7142
1.21
6.24
1.8
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1009
8628
1.20
6.23
2.5
2.6
%
22.4
22.3
0.08
828
7318
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
150
970
1.56
6.22
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
260
1875
1.40
6.22
1.2
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
347
2621
1.34
6.21
5.1
5.2
%
0.9
0.9
0.39
326
2454
(3014765) Yersinia sp identified in Stool by Organism specific culture
259
1867
1.40
6.21
1.2
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
349
2642
1.34
6.16
5.1
5.1
%
1.7
1.6
0.51
328
2469
(3023520) Reticulocytes [#/volume] in Blood
649
5327
1.24
6.06
2.4
2.6
e9/l
70.2
70.1
0.02
494
4012
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1168
10143
1.18
6.03
3.1
2.9
e6/l
2.6
3.0
0.85
652
5396
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
855
7225
1.21
5.99
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
137
878
1.57
5.93
1.4
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1511
13409
1.16
5.91
2.7
2.6
e6/l
5.1
6.0
1.46
1301
11717
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
247
1788
1.39
5.80
1.5
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
254
1848
1.39
5.79
1.2
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
316
2381
1.34
5.78
2.5
2.3
g/l
9.8
10.2
0.85
256
1991
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
852
7235
1.20
5.67
3.9
4.2
u/l
232.0
245.0
2.83
793
6818
(3008898) HLA-B27 [Presence]
258
1895
1.37
5.57
1.1
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
272
2019
1.36
5.50
5.5
6.2
mmol/l
1.3
1.3
0.11
242
1775
(3010144) Erythrocytes [#/volume] in Synovial fluid
103
629
1.65
5.47
1.5
1.4
e6/l
19683.3
108452.2
2.71
66
427
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1437
12775
1.15
5.45
4.4
4.2
%
21.9
21.9
0.06
632
6180
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
102
625
1.64
5.35
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
523
4256
1.25
5.30
4.4
4.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
131
856
1.54
5.25
1.4
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1903
17285
1.14
5.24
3.3
3.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
598
4944
1.23
5.24
4.1
4.2
%
0.0
0.4
1.78
131
1239
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
74
418
1.78
5.22
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
383
3010
1.29
5.20
2.0
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
131
859
1.53
5.18
1.3
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1890
17182
1.13
5.12
4.2
4.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
826
7061
1.19
5.11
2.4
2.5
%
1.8
1.8
0.37
726
6253
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
73
414
1.77
5.09
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
208
1498
1.40
5.09
1.4
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
1393
12414
1.15
5.08
3.0
2.8
mosm/kgh2o
531.1
534.6
0.24
1159
10527
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
131
863
1.53
5.08
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1813
16446
1.14
5.08
3.8
3.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
130
856
1.53
5.05
1.3
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
131
867
1.52
4.98
1.4
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
329
2551
1.30
4.97
2.5
2.3
g/l
7.4
7.5
0.34
244
1910
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
328
2546
1.30
4.91
2.5
2.3
g/l
3.8
3.8
0.02
240
1818
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
328
2548
1.30
4.89
2.5
2.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
605
5049
1.22
4.84
3.9
4.0
%
0.6
0.6
0.16
121
1147
(3017181) Myelocytes/100 leukocytes in Blood
657
5529
1.21
4.83
4.0
4.1
%
0.9
0.9
0.02
158
1587
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
251
1881
1.35
4.82
1.6
1.6
iu/ml
0.3
5.4
0.90
46
411
(3012494) Peanut IgE Ab [Units/volume] in Serum
32
137
2.34
4.81
1.1
1.1
u/ml
1.6
1.5
0.02
15
65
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
495
4053
1.24
4.77
3.2
3.3
pmol/l
4.4
4.4
0.29
430
3586
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
239
1784
1.35
4.72
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
788
6762
1.18
4.67
1.7
1.6
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
141
963
1.47
4.63
1.7
1.9
pmol/l
185.1
201.7
1.28
133
907
(3002385) Erythrocyte distribution width [Ratio]
5368
51915
1.12
4.63
18.9
17.8
%
13.7
13.7
0.25
5264
50811
(3000475) Leukocytes [#/volume] in Synovial fluid
219
1620
1.36
4.59
1.8
1.6
e6/l
14131.0
11966.8
0.36
157
1165
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
946
8254
1.17
4.57
5.1
4.6
%
32.1
32.9
1.26
622
5479
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
308
2399
1.30
4.53
2.5
2.3
g/l
2.9
3.1
2.57
241
1863
(3000492) Spirometry study
692
5897
1.19
4.45
1.5
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
623
5266
1.20
4.38
4.1
4.2
%
0.1
0.1
0.73
150
1475
(3019420) Tryptase [Mass/volume] in Serum or Plasma
59
330
1.79
4.37
1.4
1.5
ug/l
6.5
8.9
1.45
54
295
(4062490)
101
655
1.55
4.27
1.8
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
532
4442
1.21
4.27
1.4
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1195
10680
1.14
4.14
2.9
3.2
mmol/l
0.8
0.8
0.24
1107
9956
(3033923) Metanephrine [Moles/time] in 24 hour Urine
31
141
2.20
4.10
1.0
1.1
umol/24h
0.6
0.7
0.69
11
62
(3003458) Phosphate [Moles/volume] in Serum or Plasma
942
8290
1.16
4.07
5.1
5.7
mmol/l
1.0
1.0
2.53
884
7698
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
775
6724
1.17
4.03
1.8
1.7
%
1.5
1.5
0.79
681
5841
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
844
7390
1.16
3.91
2.3
2.7
umol/l
7.0
8.2
1.32
724
6408
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
226
1726
1.32
3.89
2.2
2.0
mg/l
10.6
11.5
0.96
206
1589
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
615
5252
1.19
3.88
2.5
2.6
ml/min/173m2
64.6
64.4
0.06
260
2091
(3024980) IgG subclass 4 [Mass/volume] in Serum
143
1016
1.42
3.88
1.9
1.6
g/l
0.6
0.8
1.17
110
751
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
340
2737
1.25
3.88
2.2
1.9
u/l
40.6
39.3
0.55
294
2403
(3019832) Treponema pallidum Ab [Presence] in Serum
409
3362
1.23
3.86
1.6
1.6
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
40
206
1.95
3.85
1.3
1.2
g/l
0.3
0.3
0.03
28
166
(3028192) IgG subclass 2 [Mass/volume] in Serum
99
657
1.51
3.81
1.7
1.4
g/l
3.1
2.8
0.64
75
446
(3024139) IgG subclass 3 [Mass/volume] in Serum
99
657
1.51
3.81
1.7
1.4
g/l
0.4
0.4
0.86
78
447
(3017732) Neutrophils [#/volume] in Blood
524
4424
1.20
3.77
2.7
3.0
e9/l
4.0
4.1
0.30
381
3380
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
119
822
1.45
3.77
1.7
1.6
%
59.7
58.4
0.12
70
507
(3030981) Hyaline casts [#/volume] in Urine by Automated count
394
3245
1.23
3.66
2.7
2.7
e6/l
0.3
0.3
0.12
379
3160
(3025018) Bordetella pertussis Ab [Titer] in Serum
58
342
1.70
3.64
1.3
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
193
1458
1.33
3.61
6.5
7.1
mmol/l
11.2
11.2
0.05
174
1305
(3018572) Chloride [Moles/volume] in Blood
193
1459
1.33
3.60
6.5
7.1
mmol/l
105.3
105.1
0.29
174
1306
(3027135) IgG subclass 1 [Mass/volume] in Serum
98
658
1.50
3.59
1.8
1.4
g/l
6.7
6.8
0.14
76
447
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
30
143
2.10
3.57
2.5
2.2
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
34
172
1.98
3.47
2.1
2.0
mg/l
8.9
9.2
0.11
28
139
(3009214) Lutropin [Units/volume] in Serum or Plasma
162
1200
1.36
3.47
1.3
1.3
u/l
11.4
12.1
0.24
132
966
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
77
495
1.56
3.46
1.2
1.2
titre
220.8
157.2
0.29
13
94
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
122
862
1.42
3.46
1.9
2.1
mg/l
35.4
24.0
1.05
27
222
(3007916) DNA double strand Ab [Titer] in Serum
20
82
2.44
3.37
1.2
1.2
—
112.4
—
0
5
(3013945) Hepatitis B virus e Ab [Presence] in Serum
10
27
3.71
3.35
1.0
1.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
749
6605
1.15
3.17
6.6
7.4
%
96.2
95.7
2.06
716
6345
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
100
694
1.45
3.15
1.4
1.4
u/l
37.2
32.8
0.57
85
554
(3002173) Hemoglobin [Mass/volume] in Arterial blood
697
6124
1.15
3.11
7.0
7.8
g/l
121.3
120.7
0.37
668
5898
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
299
2440
1.23
3.09
1.9
1.8
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
60
375
1.60
3.07
1.3
1.6
u/l
5.2
6.3
1.25
53
314
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
68
438
1.56
3.07
1.8
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
504
4327
1.18
3.04
3.2
3.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
13
45
2.89
3.02
1.1
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
429
3637
1.19
3.00
1.4
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
250
2008
1.25
2.99
2.3
2.2
g/l
38.5
37.6
1.49
214
1712
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
75
498
1.51
2.97
1.3
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
828
7389
1.14
2.95
6.4
7.0
mmol/l
1.1
1.1
0.02
633
5817
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
206
1621
1.28
2.93
1.4
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
102
722
1.42
2.92
1.1
1.1
u/ml
2.0
1.8
0.04
25
164
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
138
1030
1.35
2.88
1.8
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
77
519
1.49
2.85
1.1
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
631
5549
1.15
2.80
6.2
7.3
mmol/l
9.0
9.9
2.48
592
5299
(3011412) CD3 cells [#/volume] in Blood
86
595
1.45
2.80
2.1
2.3
e9/l
1.2
1.1
0.35
56
360
(3021788) Differential panel - Synovial fluid
159
1218
1.31
2.79
1.7
1.5
—
—
—
0
0
(3012544) pH of Venous blood
672
5939
1.14
2.78
3.6
3.7
ph
7.4
7.4
—
6
27
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.4
mg/l
0.7
2.9
—
5
19
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.4
mg/l
0.1
1.0
—
5
18
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.4
mg/l
0.2
2.4
—
5
21
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.4
mg/l
0.2
1.5
—
5
19
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.4
mg/l
2.5
4.0
—
5
19
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.4
mg/l
1.0
3.4
—
5
20
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.4
mg/l
0.2
0.7
—
5
18
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
40
232
1.73
2.74
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
195
1540
1.27
2.72
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
93
657
1.42
2.72
1.2
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
95
675
1.41
2.69
1.1
1.1
—
2.6
—
0
7
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
37
2.98
2.69
1.1
1.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
825
7410
1.13
2.66
6.4
7.0
kpa
5.1
5.1
0.27
778
7059
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1080
9851
1.11
2.66
1.9
2.1
s
29.7
29.7
0.05
1039
9555
(3023430) Cat dander IgE Ab [Units/volume] in Serum
84
586
1.44
2.64
1.0
1.1
u/ml
6.0
3.4
0.40
36
210
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
59
383
1.54
2.62
1.1
1.1
iu/ml
4.2
11.4
2.81
13
99
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
318
2662
1.20
2.60
2.0
1.9
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
29
155
1.87
2.60
2.3
2.0
ug/l
1.4
2.3
2.01
15
83
(3052592) Norovirus Ag [Presence] in Stool
25
127
1.97
2.59
1.1
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
71
482
1.48
2.57
1.1
1.0
mg/l
287.1
290.3
0.13
64
431
(3027801) Oxygen [Partial pressure] in Arterial blood
823
7408
1.12
2.57
6.4
7.0
kpa
12.5
12.4
0.17
777
7054
(3017704) Immunofixation for Urine
54
346
1.56
2.55
1.8
1.7
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
5
7
7.15
2.55
1.0
1.1
titre
1076.0
1625.7
—
5
7
(3014133) Dog dander IgE Ab [Units/volume] in Serum
88
624
1.42
2.54
1.1
1.1
u/ml
1.1
2.7
2.25
36
220
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
58
379
1.53
2.52
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
74
509
1.46
2.52
1.4
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
49
308
1.59
2.51
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
58
380
1.53
2.49
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
68
462
1.48
2.47
1.9
2.0
%
15.4
15.4
0.01
30
185
(3000093) Morphology [Interpretation] in Blood Narrative
83
586
1.42
2.47
1.2
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
592
5236
1.14
2.45
3.2
3.6
ng/l
86.7
89.5
0.32
501
4447
(3029075) Extractable nuclear Ab panel - Serum
31
173
1.80
2.45
1.0
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
45
279
1.62
2.45
1.1
1.0
u/ml
18.0
1.9
0.42
12
80
(3052851) Hemolysis interference index of Serum or Plasma
244
2004
1.22
2.44
2.7
3.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
136
1041
1.31
2.44
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
166
1306
1.28
2.43
3.2
3.7
%
57.4
57.7
0.12
166
1306
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
10
34
2.94
2.41
1.0
1.1
u/ml
0.1
0.1
—
5
15
(3027273) Bicarbonate [Moles/volume] in Venous blood
350
2982
1.18
2.38
3.7
3.4
mmol/l
25.4
25.3
0.21
341
2897
(3007919) Fasciola sp Ab [Titer] in Serum
5
8
6.25
2.37
1.0
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
219
1789
1.23
2.33
2.4
2.3
g/l
0.0
0.0
0.35
205
1625
(3034274) Bile acid [Moles/volume] in Serum --fasting
66
452
1.46
2.32
1.8
1.8
umol/l
11.0
9.1
0.25
51
310
(1761482) Bacteria [#/volume] in Urine by Culture
202
1638
1.24
2.30
5.7
4.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
66
455
1.45
2.26
1.2
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
43
270
1.60
2.25
1.0
1.0
u/ml
7.8
0.5
—
8
63
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
57
382
1.50
2.24
2.1
2.5
e9/l
0.2
0.2
0.35
52
333
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
17
79
2.15
2.24
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
53
350
1.52
2.23
1.0
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
59
399
1.48
2.22
2.1
2.5
e6/l
465.7
525.6
0.53
53
337
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
20
100
2.00
2.20
1.2
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
214
1757
1.22
2.19
2.4
2.3
g/l
0.0
0.0
0.00
201
1621
(3006922) Hepatitis E virus Ab [Presence] in Serum
61
417
1.47
2.19
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
29
165
1.76
2.18
1.1
1.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
18
87
2.07
2.16
1.0
1.0
ug/l
85.3
79.5
0.19
12
70
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
188
1525
1.24
2.16
1.6
1.6
—
—
—
0
0
(4038314)
6
14
4.29
2.15
1.5
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
64
444
1.45
2.13
1.2
1.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
48
314
1.53
2.12
2.4
2.7
—
31.4
—
0
5
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
231
1920
1.21
2.10
2.4
2.2
g/l
0.0
0.0
0.08
216
1751
(3006184) Hemoglobin [Mass/volume] in Capillary blood
179
1449
1.24
2.10
2.4
2.2
g/l
131.1
127.9
0.93
124
1018
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
45
291
1.55
2.10
1.5
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
385
3345
1.16
2.09
4.6
3.5
—
—
—
0
0
(4281824)
59
845
0.70
2.08
1.2
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
43
276
1.56
2.07
1.1
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
13
56
2.32
2.04
1.1
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
69
491
1.41
2.02
1.9
2.2
%
47.3
40.4
0.69
11
62
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
199
1640
1.22
1.99
1.3
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
634
5721
1.12
1.95
3.5
3.7
kpa
5.8
5.8
0.05
619
5566
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
258
2185
1.19
1.94
2.4
2.4
g/l
1.1
0.9
0.35
225
1871
(3046682) IgA [Presence] in Skin by Immunofluorescence
5
11
4.55
1.94
1.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
16
3.75
1.93
1.2
1.2
%
1.7
2.1
—
6
16
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
31
187
1.66
1.93
1.2
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
107
826
1.30
1.89
1.0
1.1
u/ml
6.1
4.0
0.50
54
383
(4034850)
247
2091
1.19
1.88
10.5
9.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
452
4006
1.14
1.88
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
125
987
1.27
1.86
1.6
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
259
2206
1.18
1.84
2.5
2.3
ug/l
254.1
621.4
2.61
242
2076
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
30
182
1.65
1.84
1.5
1.6
ug/l
0.6
0.4
1.22
18
117
(3049717) Cytology report of Urine Cyto stain
266
2272
1.18
1.83
2.4
2.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
398
3505
1.14
1.83
8.3
9.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
166
1357
1.23
1.83
1.3
1.3
mmol/l
3.8
3.8
0.07
154
1274
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
109
848
1.29
1.82
1.1
1.1
g/l
1.5
1.5
0.31
99
757
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
138
1106
1.25
1.82
1.1
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
83
622
1.34
1.81
1.4
1.5
%
25.6
30.5
0.63
46
376
(3045716) Anion gap in Serum or Plasma
44
294
1.50
1.81
2.5
2.2
mmol/l
8.2
9.4
1.59
29
226
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1651
15613
1.07
1.80
2.3
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
109
851
1.29
1.78
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
297
2568
1.16
1.77
3.7
4.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
126
1003
1.26
1.77
1.0
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
232
1969
1.18
1.74
3.4
4.2
mmol/l
3.9
3.9
0.06
221
1845
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
333
2909
1.15
1.73
1.6
1.7
g/l
1.5
1.6
1.54
287
2490
(3018405) Lactate [Moles/volume] in Arterial blood
267
2294
1.17
1.73
3.2
4.0
mmol/l
1.4
1.3
0.16
262
2254
(3017354) Segmented neutrophils/100 leukocytes in Blood
87
663
1.32
1.71
3.7
3.5
%
58.0
58.1
0.02
52
432
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
73
542
1.35
1.71
1.2
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
18
96
1.88
1.70
1.1
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
29
179
1.62
1.69
1.2
1.3
%
37.2
34.7
0.12
16
116
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
436
4881
0.89
1.68
1.7
1.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
241
2060
1.18
1.67
1.3
1.3
iu/l
28.7
34.7
2.31
214
1756
(3037121) Protein [Mass/volume] in Urine
258
2218
1.17
1.67
2.6
3.0
g/l
0.4
0.3
0.95
107
862
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
63
459
1.38
1.67
1.3
1.4
mmol/l
2.0
2.1
1.07
57
431
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
38
252
1.51
1.64
1.9
2.2
ug/l
27.3
249.1
0.91
32
233
(3047007) Chlamydophila sp Ab [Presence] in Serum
105
827
1.27
1.63
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
176
1468
1.20
1.62
1.6
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
626
5713
1.10
1.60
3.5
3.7
mmol/l
1.8
2.0
0.54
516
4671
(3008757) Leukocyte morphology finding [Identifier] in Blood
90
699
1.29
1.57
4.0
4.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
82
630
1.30
1.55
3.6
3.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
64
854
0.75
1.54
3.1
5.1
umol/l
346.4
361.2
0.31
54
743
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
68
509
1.34
1.54
1.3
1.6
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
21
122
1.72
1.54
1.3
1.3
—
109.8
—
0
20
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
13
64
2.03
1.54
1.2
1.0
u/ml
0.6
1.6
—
8
45
(3003721) Smooth muscle Ab [Units/volume] in Serum
8
33
2.43
1.53
1.1
1.2
—
1.2
—
0
6
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
433
3885
1.12
1.53
3.2
3.6
kpa
5.1
5.2
1.14
391
3588
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
22
130
1.69
1.52
1.8
1.6
ng/l
113.9
123.6
0.17
22
130
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
5
15
3.33
1.52
1.2
1.3
nmol/l
562.9
420.7
—
5
15
(3010503) CD19 cells [#/volume] in Blood
55
400
1.38
1.50
2.4
2.4
e9/l
0.2
0.3
0.54
55
385
(3021901) Oxygen saturation in Capillary blood
136
1116
1.22
1.50
2.9
2.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
865
8041
1.09
1.49
6.3
6.8
mmol/l
104.5
104.3
0.59
845
7866
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
90
705
1.28
1.49
1.6
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
43
607
0.71
1.49
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
153
1272
1.21
1.48
1.6
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
183
1547
1.19
1.48
1.4
1.3
mg/l
521.6
537.9
0.21
173
1464
(3021387) Prolactin [Units/volume] in Serum or Plasma
174
1465
1.19
1.48
1.8
1.7
mu/l
291.0
307.3
0.34
159
1320
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
61
453
1.35
1.47
1.2
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
162
1356
1.20
1.47
1.3
1.4
e6/l
23.8
34.0
0.28
122
1049
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
170
1431
1.19
1.45
1.3
1.3
miu/ml
231.4
217.6
0.19
73
634
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
162
1358
1.20
1.45
1.4
1.4
e6/l
969.5
1221.5
0.21
130
1104
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
35
510
0.68
1.45
1.8
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
114
924
1.24
1.42
1.1
1.1
u/ml
2.9
1.5
0.42
47
342
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
37
253
1.46
1.42
3.5
2.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
419
3773
1.12
1.41
3.5
3.2
g/l
127.7
128.3
0.19
411
3671
(3028626) Oxygen [Partial pressure] in Capillary blood
157
1317
1.20
1.40
2.8
2.8
kpa
8.1
8.1
0.05
143
1218
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
29
2.42
1.39
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
135
1118
1.21
1.38
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
158
1329
1.19
1.37
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
158
1329
1.19
1.37
1.3
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
119
974
1.23
1.37
1.3
1.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
41
2.20
1.36
1.7
2.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
23
2.61
1.36
1.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
282
3193
0.88
1.36
1.5
1.5
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
23
143
1.61
1.34
1.4
1.4
g/l
24.7
26.2
0.17
18
110
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
664
6135
1.09
1.34
2.4
2.4
u/l
41.6
45.4
0.13
561
5223
(3009343) pH of Capillary blood
424
3833
1.11
1.34
3.2
3.6
ph
7.4
7.4
0.41
58
500
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
46
332
1.39
1.34
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
28
183
1.53
1.34
1.0
1.1
%
85.6
89.2
0.19
15
89
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
9
42
2.14
1.33
1.3
1.2
nmol/l
6.1
4.3
—
9
42
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
132
1096
1.21
1.33
1.6
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
207
1788
1.16
1.32
1.7
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
106
861
1.23
1.32
1.4
1.3
nmol/l
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
46
333
1.38
1.32
2.4
2.9
%
39.2
38.7
0.06
25
118
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
46
335
1.38
1.28
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
46
335
1.38
1.28
1.3
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
291
2583
1.13
1.27
2.0
1.9
ug/l
2.2
2.1
0.07
246
2286
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
56
422
1.33
1.26
1.3
1.3
u/ml
0.9
0.9
0.03
21
211
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
106
867
1.23
1.25
1.5
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
77
1.82
1.25
1.6
1.4
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
34
236
1.44
1.24
1.6
1.5
pmol/l
15.6
15.9
0.12
29
200
(3016650) Hepatitis A virus Ab [Presence] in Serum
117
969
1.21
1.23
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
98
797
1.23
1.23
1.0
1.1
u/ml
1.6
1.2
0.21
43
313
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
27
179
1.51
1.23
1.0
1.2
%
90.7
88.9
0.09
14
91
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
54
407
1.33
1.22
2.2
2.6
e6/l
727.8
684.5
0.13
25
180
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
174
1494
1.17
1.22
2.4
2.3
ug/min
91.1
96.0
0.08
98
881
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
5
19
2.63
1.21
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
182
1570
1.16
1.21
2.5
2.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
406
3687
1.11
1.20
3.2
3.5
mmol/l
1.4
1.9
1.61
306
2771
(3024354) Oxygen [Partial pressure] in Venous blood
509
4674
1.10
1.20
3.0
3.1
kpa
4.5
4.6
0.43
493
4531
(3015235) Bicarbonate [Moles/volume] in Capillary blood
179
1543
1.16
1.20
2.8
3.1
mmol/l
24.5
25.0
0.90
149
1346
(3036048) Francisella tularensis Ab [Titer] in Serum
21
132
1.59
1.20
1.0
1.1
—
296.0
—
0
5
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
21
132
1.59
1.20
1.1
1.3
mg/l
0.6
52.9
0.73
13
96
(3044640) Blood type and Crossmatch panel - Blood
2121
20454
1.05
1.20
2.4
2.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
151
1287
1.18
1.17
3.1
2.8
umol/l
33.1
34.0
0.18
126
1100
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
16
94
1.70
1.17
10.9
7.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
33
0.00
1.16
0.0
4.8
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
33
0.00
1.16
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
41
299
1.37
1.16
1.2
1.2
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
34
0.00
1.16
0.0
12.6
—
115.8
—
0
27
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
20
126
1.59
1.14
1.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
37
266
1.39
1.14
2.1
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
84
679
1.24
1.13
1.5
2.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
26
175
1.49
1.12
3.5
2.8
mg/l
8.4
7.6
0.31
19
142
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
30
2.33
1.12
1.0
1.8
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
8
40
2.00
1.12
1.3
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
76
609
1.25
1.11
1.5
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
36
259
1.39
1.11
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
406
1.31
1.10
1.3
1.5
—
—
—
0
0
(1002224) Polysomnography panel
262
2337
1.13
1.10
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
43
320
1.35
1.09
1.4
1.5
%
3.5
3.6
—
8
72
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
8
41
1.95
1.08
1.1
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
44
329
1.34
1.08
1.1
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
422
3869
1.10
1.06
1.8
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
117
986
1.19
1.06
1.3
1.3
nmol/l
0.7
2.2
0.69
110
951
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
158
1367
1.16
1.05
1.6
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
92
759
1.21
1.04
1.2
1.2
u/l
64.6
58.6
0.39
62
506
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
48
366
1.31
1.04
1.3
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
25
170
1.47
1.04
1.2
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
34
246
1.38
1.03
2.0
2.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
21
138
1.52
1.02
1.2
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
21
138
1.52
1.02
9.3
7.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
120
1405
0.85
0.99
4.3
3.5
mg/l
20.4
27.1
1.67
74
861
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
24
164
1.46
0.98
1.3
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
40
300
1.34
0.98
1.1
1.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
23
2.17
0.98
1.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
14
84
1.67
0.97
1.2
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
39
292
1.34
0.97
5.3
5.0
u/ml
1991.1
646.1
—
9
52
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
47
362
1.30
0.97
1.3
1.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
37
275
1.35
0.96
2.1
2.0
%
7.3
8.7
0.30
37
266
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
31
0.00
0.96
0.0
1.0
—
101.6
—
0
18
(3006270) Folate [Moles/volume] in Blood
68
550
1.24
0.95
1.1
1.1
nmol/l
386.8
356.0
0.50
46
468
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
32
0.00
0.95
0.0
3.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
130
1119
1.16
0.94
1.4
1.5
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
20
133
1.51
0.94
1.4
2.1
e6/l
159.2
147.7
0.10
12
64
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
102
1203
0.85
0.93
1.5
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
213
1900
1.12
0.93
1.2
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
30
217
1.38
0.93
1.9
1.9
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
9
52
1.73
0.92
2.0
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
49
383
1.28
0.92
1.1
1.1
nmol/l
1.1
8.9
—
7
80
(3023511) Choriogonadotropin [Units/volume] in Urine
70
572
1.23
0.90
1.3
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
11
63
1.75
0.90
1.0
1.2
umol/24h
1.7
1.7
0.03
11
63
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
74
609
1.22
0.90
2.9
3.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
35
262
1.34
0.89
1.2
2.0
%
143.4
155.4
0.51
35
245
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
65
529
1.23
0.88
1.0
1.0
u/ml
0.8
0.3
0.29
11
120
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
32
427
0.75
0.88
1.3
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
83
693
1.20
0.87
2.5
2.9
%
13.4
13.2
0.87
83
684
(3050129) First trimester maternal screen panel - Serum or Plasma
63
771
0.82
0.87
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
104
887
1.17
0.87
1.5
1.5
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
6
30
2.00
0.87
2.3
1.8
—
0.1
—
0
7
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
115
989
1.17
0.87
1.3
1.3
nmol/l
0.2
0.3
—
7
69
(44806118)
83
694
1.20
0.86
1.7
1.5
—
—
—
0
0
(44790047)
83
694
1.20
0.86
1.7
1.5
—
—
—
0
0
(44790049)
83
694
1.20
0.86
1.7
1.5
—
—
—
0
0
(44790048)
83
694
1.20
0.86
1.7
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
155
1364
1.14
0.86
1.6
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
94
1106
0.85
0.85
1.3
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
44
343
1.28
0.85
1.4
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
105
898
1.17
0.85
1.3
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
18
120
1.50
0.85
9.9
7.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
26
187
1.39
0.84
1.6
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
100
855
1.17
0.82
1.3
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
84
993
0.84
0.82
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
88
1036
0.85
0.82
1.3
1.2
u/ml
278.8
284.4
0.07
51
642
(3030313) Adrenal Ab [Titer] in Serum
6
32
1.88
0.81
1.0
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
97
828
1.17
0.81
4.2
6.6
mg/l
11.0
12.0
1.13
87
760
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
228
2062
1.11
0.81
3.1
3.2
ratio
2.8
1.9
0.27
13
166
(40768441) Liver Pathology biopsy report
59
481
1.23
0.80
1.3
1.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
29
215
1.35
0.80
1.2
1.2
g/l
39.7
38.4
0.14
13
111
(3022493) Free Hemoglobin [Mass/volume] in Plasma
33
250
1.32
0.79
1.4
4.9
mg/l
70.6
861.9
0.49
22
182
(4015189)
25
181
1.38
0.79
2.8
2.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
115
998
1.15
0.79
1.3
1.2
—
—
—
0
0
(4094501)
199
1790
1.11
0.79
1.1
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
264
2410
1.10
0.79
3.4
3.8
mmol/l
24.7
25.0
0.88
246
2211
(3011325) HIV 1+2 Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
25
0.00
0.79
0.0
5.5
—
396.6
—
0
25
(3024928) Oxygen saturation in Venous blood
145
1280
1.14
0.78
2.9
3.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
26
190
1.37
0.78
2.9
3.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
43
339
1.27
0.78
1.0
1.3
u/l
395.1
289.2
0.19
34
314
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
142
1254
1.13
0.77
1.3
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
96
824
1.17
0.77
2.5
2.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
208
1881
1.11
0.76
1.8
1.7
—
—
—
0
0
(3036603) Volume of Urine
54
440
1.23
0.75
1.3
1.5
ml
1611.1
1858.1
—
9
104
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
239
2179
1.10
0.75
2.6
2.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
12
75
1.60
0.74
1.0
1.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
233
2122
1.10
0.74
3.1
3.3
mg/l
40.1
49.7
0.52
198
1717
(3034860) Kappa light chains.free [Mass/volume] in Serum
233
2123
1.10
0.74
3.1
3.3
mg/l
42.3
80.2
0.79
196
1717
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
91
781
1.17
0.74
1.2
1.2
mmol/l
7.9
7.4
0.50
71
578
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
19
266
0.71
0.73
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
302
2787
1.09
0.73
3.1
3.7
—
—
—
0
0
(3004451) EKG impression Narrative
40
316
1.27
0.73
1.2
1.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
52
424
1.23
0.73
1.3
1.2
u/l
34.9
21.5
0.69
46
351
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
37
290
1.28
0.72
1.5
1.7
nmol/l
5.9
5.8
0.01
29
236
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
171
0.64
0.71
1.3
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
25
185
1.35
0.71
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
41
327
1.26
0.70
1.4
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
42
336
1.25
0.70
1.1
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
41
1.71
0.70
1.1
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
42
1.67
0.68
1.3
1.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
89
769
1.16
0.68
1.1
1.1
u/ml
3.2
3.2
0.02
25
322
(3001964) Herpes simplex virus Ag [Presence] in Specimen
25
187
1.34
0.68
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
959
9215
1.05
0.67
2.9
3.0
ug/l
0.8
0.8
0.06
599
6134
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
35
440
0.79
0.66
1.7
1.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
55
457
1.21
0.66
1.6
2.0
mmol/l
6.9
6.7
0.11
32
304
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
22
162
1.36
0.66
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
22
162
1.36
0.66
1.3
1.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
22
162
1.36
0.66
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
22
162
1.36
0.66
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
22
162
1.36
0.66
1.0
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
53
439
1.21
0.65
1.3
1.2
u/l
99.7
88.2
0.38
48
377
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
7
44
1.59
0.65
1.1
1.1
u/l
—
4.6
—
0
11
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
44
1.59
0.65
1.1
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
81
698
1.16
0.65
3.3
14.4
mmol/l
7.3
7.4
0.22
69
576
(3047189) Immunofixation for 24 hour Urine
24
315
0.76
0.64
1.3
1.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
78
672
1.16
0.63
1.8
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
233
2146
1.09
0.62
2.7
3.0
u/ml
0.4
0.3
0.10
126
1218
(3026692) Albumin [Mass/volume] in Peritoneal fluid
22
164
1.34
0.62
1.3
1.4
g/l
10.6
13.3
0.84
15
123
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
71
1.55
0.62
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
37
297
1.25
0.62
1.6
2.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
180
1639
1.10
0.61
1.9
1.8
iu/l
5.3
4.8
0.19
61
585
(3046861) Legionella sp Ag [Presence] in Urine
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
14
96
1.46
0.61
1.9
1.5
%
32.1
52.2
—
7
45
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
50
1.60
0.61
1.1
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
8
50
1.60
0.61
1.1
1.2
u/l
6.1
16.7
—
8
50
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
43
352
1.22
0.61
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
42
343
1.23
0.61
1.1
1.1
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
20
0.00
0.60
0.0
1.1
—
17.0
—
0
12
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
163
1480
1.10
0.59
1.4
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
96
845
1.14
0.59
1.1
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
8
52
1.54
0.59
1.8
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
127
1139
1.12
0.58
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
80
696
1.15
0.58
1.1
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
71
613
1.16
0.57
1.4
1.5
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
35
1.71
0.57
1.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
54
1.48
0.57
1.3
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
40
328
1.22
0.57
3.1
2.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
59
690
0.85
0.56
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
123
1104
1.12
0.56
1.7
1.5
—
—
—
0
0
(44806071)
11
73
1.51
0.56
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
77
671
1.15
0.56
1.3
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
79
690
1.15
0.55
2.7
3.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
41
338
1.21
0.55
1.7
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
41
338
1.21
0.55
1.7
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
41
338
1.21
0.55
1.7
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
41
338
1.21
0.55
1.7
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
27
212
1.27
0.55
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
65
560
1.16
0.55
1.1
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
44
366
1.20
0.55
2.0
2.9
ph
7.4
7.4
0.37
14
117
(3035637) Corticotropin [Mass/volume] in Plasma
89
785
1.14
0.55
1.5
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
135
1221
1.11
0.55
1.4
1.4
mmol/l
60.4
63.8
0.48
107
972
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
62
533
1.16
0.54
1.1
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
60
1.50
0.54
1.1
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
37
303
1.22
0.54
1.4
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
37
303
1.22
0.54
1.4
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1693
16527
1.03
0.54
3.9
3.9
%
91.7
90.9
0.67
1637
16126
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
70
608
1.15
0.54
1.1
1.1
—
84.5
—
0
10
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
30
240
1.25
0.53
1.2
1.1
miu/ml
1655.2
1541.8
0.24
30
240
(3027035) Albumin [Mass/time] in 24 hour Urine
9
62
1.45
0.53
1.3
1.3
—
640.5
—
0
9
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
86
760
1.13
0.52
1.8
2.0
ug/l
14.5
23.7
4.34
79
749
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
63
1.43
0.52
1.3
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
64
1.41
0.51
2.4
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
114
1028
1.11
0.50
1.3
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
407
3863
1.06
0.50
2.7
3.9
u/ml
42.5
59.1
1.19
388
3714
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
41
1.46
0.50
1.3
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
41
1.46
0.50
1.3
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
36
297
1.21
0.50
1.3
1.2
nmol/l
146.2
135.3
0.47
36
297
(3045788) Cell count panel - Pleural fluid
49
574
0.85
0.50
1.4
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
28
225
1.25
0.49
1.5
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
124
1126
1.10
0.48
2.2
2.1
u/l
6739.8
4146.2
0.31
43
471
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
320
3388
0.94
0.48
9.0
8.8
mmol/l
24.3
24.4
0.11
291
3173
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
21
163
1.29
0.48
1.2
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
64
559
1.15
0.47
1.2
1.3
nmol/l
1.5
1.5
0.01
54
506
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
158
1715
0.92
0.47
1.2
1.3
—
—
—
0
0
(44806420)
24
191
1.26
0.46
2.6
2.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
50
579
0.86
0.45
1.5
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
120
1094
1.10
0.45
4.4
3.4
%
1.4
1.4
0.02
85
859
(3048929) Epstein Barr virus Ab [Presence] in Serum
143
1553
0.92
0.44
1.3
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
77
686
1.12
0.44
1.7
1.4
mosm/kgh2o
277.9
277.0
0.13
56
522
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
130
1.31
0.43
1.2
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
13
95
1.37
0.43
1.0
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
149
1375
1.09
0.43
2.8
2.5
%
16.1
16.1
0.05
82
688
(3027456) Digoxin [Moles/volume] in Serum or Plasma
141
1299
1.09
0.43
3.0
3.1
nmol/l
0.8
0.8
1.49
105
986
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
15
196
0.76
0.42
1.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
115
1050
1.10
0.42
2.0
1.9
mmol/l
1.7
1.7
0.11
115
1027
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
87
783
1.11
0.42
3.1
3.2
nmol/l
5.9
12.4
0.42
81
763
(40768446) Kidney Pathology biopsy report
18
229
0.79
0.42
1.2
1.6
—
—
—
0
0
(40758358) Immune stain study
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
301
2853
1.06
0.42
2.3
2.7
%
0.7
0.7
0.35
288
2734
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
5
33
1.52
0.41
1.0
1.1
u/field
1.0
1.0
—
5
23
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
29
240
1.21
0.41
1.0
1.0
u/ml
0.5
2.5
—
5
36
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.6
—
47.1
—
0
11
(3011335) Digoxin [Mass/volume] in Serum or Plasma
8
60
1.33
0.40
1.3
2.3
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
11360.5
—
0
6
(3051651) Icteric interference index of Serum or Plasma
44
380
1.16
0.40
2.8
3.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
60
677
0.89
0.39
1.5
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
135
1248
1.08
0.39
5.3
5.2
iu/ml
335.3
612.2
0.73
19
171
(3028308) Erythrocytes [#/volume] in Pleural fluid
58
655
0.88
0.39
1.5
1.4
e6/l
62097.7
58185.3
0.03
33
386
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
0
19
0.00
0.39
0.0
1.1
—
0.9
—
0
12
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
50
569
0.88
0.38
2.7
2.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
31
261
1.19
0.38
1.9
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
31
261
1.19
0.38
1.9
2.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
67
1.34
0.38
2.2
2.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
41
354
1.16
0.38
1.3
1.1
ratio
1.1
1.1
0.61
18
124
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
427
4098
1.04
0.38
7.8
8.5
%
1.4
1.4
0.17
422
4069
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
68
1.32
0.37
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
35
299
1.17
0.37
7.7
11.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
190
1785
1.07
0.37
2.5
2.4
g/l
3.6
3.6
0.06
178
1691
(3042733) HLA Ab [Presence] in Serum
14
180
0.78
0.36
4.2
5.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
9
70
1.29
0.36
2.8
2.8
u/field
0.6
0.7
—
9
70
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
124
1147
1.08
0.36
1.5
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
226
2139
1.06
0.35
1.8
1.7
mg/l
5.1
3.6
0.79
165
1549
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
80
0.62
0.35
1.6
5.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
19
153
1.24
0.35
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
108
1.30
0.35
1.4
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
31
264
1.17
0.34
1.9
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
18
222
0.81
0.34
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
69
763
0.90
0.34
1.7
1.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
11
82
1.34
0.34
1.5
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
12
91
1.32
0.33
1.6
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
13
100
1.30
0.33
1.0
1.1
u/ml
55.7
52.8
0.04
13
95
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
70
634
1.11
0.33
1.1
1.1
—
4.0
—
0
9
(3002523) Influenza virus A Ag [Presence] in Specimen
71
782
0.91
0.33
1.0
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
110
1019
1.08
0.32
1.4
1.4
u/ml
111.2
117.0
0.32
28
214
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
29
247
1.17
0.32
1.1
1.1
ng/l
95.6
385.4
—
9
61
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
19
155
1.23
0.32
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
27
229
1.18
0.32
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
15
187
0.80
0.32
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
47
528
0.89
0.31
2.4
2.2
u/field
2.8
2.1
0.21
24
214
(3016038) Potassium [Moles/volume] in Urine
50
446
1.12
0.31
1.1
1.1
mmol/l
36.2
33.6
0.28
43
379
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
67
608
1.10
0.31
4.4
4.9
u/ml
227.4
78.8
0.48
19
167
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
170
1604
1.06
0.31
2.3
3.0
mg/l
1.5
1.6
0.24
154
1470
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
20
165
1.21
0.31
1.2
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
30
258
1.16
0.30
2.2
1.2
—
—
—
0
0
(4198724)
15
186
0.81
0.30
4.1
2.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
99
0.71
0.30
1.0
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
42
371
1.13
0.30
1.1
1.1
u/l
15.5
26.5
1.75
32
277
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
102
1.27
0.30
1.2
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
24
203
1.18
0.29
2.0
2.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
67
734
0.91
0.29
1.4
1.5
e6/l
1400.9
2229.7
1.63
47
537
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
118
1262
0.93
0.29
2.5
3.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
60
544
1.10
0.29
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
106
0.75
0.29
1.1
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
107
0.75
0.29
1.7
2.7
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
1.0
1.1
—
9.4
—
0
11
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
57
1.23
0.29
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
305
2931
1.04
0.28
3.1
4.0
mmol/l
24.0
24.3
1.19
270
2635
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
24
204
1.18
0.28
2.0
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
24
204
1.18
0.28
2.0
3.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
36
317
1.14
0.28
1.1
1.1
u/l
1.1
1.1
0.04
14
162
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
50
450
1.11
0.28
1.0
1.0
ng/l
292.2
335.9
0.64
36
317
(3051101) Glucose [Moles/volume] in Cord blood
9
117
0.77
0.27
6.6
7.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
50
451
1.11
0.27
1.0
1.0
ng/l
841.3
722.6
0.92
37
306
(3003740) Influenza virus B Ag [Presence] in Specimen
72
782
0.92
0.27
1.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
51
461
1.11
0.27
1.5
1.6
u/l
4.9
6.3
0.42
26
221
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
61
557
1.10
0.26
1.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
61
557
1.10
0.26
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
61
557
1.10
0.26
1.6
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
157
1488
1.06
0.26
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
95
1.26
0.26
1.3
1.5
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
71
0.70
0.26
1.2
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
92
857
1.07
0.26
1.9
1.8
%
89.8
89.8
0.02
92
846
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
77
1.30
0.26
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
12
149
0.81
0.25
1.3
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2118
21425
0.98
0.25
3.1
2.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
25
288
0.87
0.25
1.3
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
44
396
1.11
0.25
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
99
926
1.07
0.25
1.9
3.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
9
74
1.22
0.25
2.9
2.7
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
50
454
1.10
0.25
1.0
1.0
ng/l
38.8
44.7
0.52
36
313
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
79
850
0.93
0.24
1.2
1.1
%
119.6
118.1
0.17
70
760
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
12
96
1.25
0.24
1.7
1.4
%
3.0
9.5
—
7
52
(3003694) ABO and Rh group [Type] in Blood
1629
16507
0.98
0.24
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
551
5373
1.03
0.24
4.5
4.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
15
124
1.21
0.24
1.5
2.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
23
199
1.16
0.23
1.2
1.8
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.6
1.7
umol/l
1.5
1.4
—
5
33
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
20
171
1.17
0.23
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
89
950
0.94
0.23
1.6
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
50
546
0.92
0.22
1.3
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
103
1092
0.94
0.22
1.6
2.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
41
1.22
0.22
5.8
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
77
824
0.93
0.22
1.5
1.5
g/l
34.1
32.6
0.41
67
745
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
41
372
1.10
0.21
1.1
1.1
u/l
78.1
84.5
0.28
32
284
(3024869) Neuronal Ab [Presence] in Serum
10
124
0.81
0.21
1.0
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
97
914
1.06
0.21
1.8
1.4
mu/l
43.8
57.7
0.81
87
811
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
84
788
1.07
0.21
2.1
2.3
pg
33.1
32.7
0.33
84
782
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
12
0.00
0.21
0.0
3.5
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
690
6765
1.02
0.21
3.2
3.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
18
154
1.17
0.21
1.8
1.9
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
43
1.16
0.21
2.4
4.7
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.4
—
2.0
—
0
13
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
1.3
—
2664.3
—
0
13
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
17
145
1.17
0.20
1.1
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
14
0.00
0.20
0.0
6.9
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
14
0.00
0.20
0.0
6.4
—
—
—
0
0
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
0
14
0.00
0.20
0.0
5.6
—
56.4
—
0
5
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
16
136
1.18
0.20
1.2
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
13
108
1.20
0.20
1.3
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
375
3850
0.97
0.20
6.4
6.8
mmol/l
24.9
24.9
0.03
370
3827
(3035880) pH of Pleural fluid
37
336
1.10
0.19
1.5
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
28
250
1.12
0.19
1.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
35
317
1.10
0.19
2.0
2.1
ug/min
74.4
209.7
—
8
71
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
67
626
1.07
0.19
2.0
1.7
—
—
—
0
0
(3036489) Thrombin time
223
2307
0.97
0.19
2.1
2.0
s
21.4
21.4
0.04
191
2023
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
18
207
0.87
0.19
1.7
1.9
e6/l
1854.4
19840.7
—
9
114
(4024509)
74
695
1.07
0.19
1.7
1.6
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
22
249
0.88
0.19
26.0
33.3
ug/l
7.2
7.3
0.10
17
225
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
91
861
1.06
0.18
1.4
1.3
pmol/l
315.3
310.2
0.04
77
664
(3020191) Ethanol [Moles/volume] in Serum or Plasma
49
453
1.08
0.18
1.2
1.5
promille
1.3
1.2
0.11
40
345
(3028707) Methadone [Presence] in Urine by Screen method
69
647
1.07
0.18
2.1
2.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
19
217
0.88
0.18
1.3
1.5
mmol/l
8.0
8.1
0.02
13
123
(3042631) Mycobacterium sp identified in Specimen
94
891
1.06
0.18
2.7
2.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
13
153
0.85
0.18
1.6
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
570
5593
1.02
0.17
3.4
3.9
mmol/l
1.2
1.2
0.40
503
4871
(3012501) Base excess in Blood by calculation
151
1452
1.04
0.17
4.1
4.2
mmol/l
2.3
2.6
0.92
120
1034
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
7
63
1.11
0.17
1.1
1.0
—
—
—
0
0
(4212803)
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
58
619
0.94
0.17
1.4
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
68
1.18
0.16
1.0
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
46
427
1.08
0.16
1.1
1.2
mg/l
43.9
42.2
0.09
40
357
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
58
618
0.94
0.16
1.4
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
65
612
1.06
0.16
2.6
3.0
mg/l
53.8
38.8
0.25
50
445
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
14
162
0.86
0.16
1.1
1.1
pmol/l
189.8
298.3
—
9
116
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
71
1.13
0.16
1.0
1.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
13
151
0.86
0.15
3.3
2.5
mmol/l
8.7
7.5
—
8
91
(3044007) Cell count panel - Peritoneal fluid
17
193
0.88
0.15
2.6
2.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
130
1.15
0.15
1.1
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
79
0.76
0.15
2.2
3.4
umol/l
29.2
40.9
—
6
66
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
24
216
1.11
0.15
1.9
2.8
umol/l
26.7
29.2
0.75
17
157
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
58
616
0.94
0.15
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
58
616
0.94
0.15
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
161
0.87
0.15
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
192
0.89
0.14
1.3
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
87
0.80
0.14
1.7
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
169
1.12
0.14
1.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
252
2457
1.03
0.14
3.2
3.4
u/ml
539.3
2571.1
1.05
211
2085
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
25
227
1.10
0.14
1.7
1.4
—
1680868.2
—
0
11
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
27
295
0.91
0.14
1.1
1.1
u/ml
5.1
4.2
—
5
47
(4146454)
78
744
1.05
0.13
3.1
2.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
125
1206
1.04
0.13
1.4
1.7
nmol/l
0.9
0.8
0.59
92
1008
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
24
218
1.10
0.13
1.5
1.4
%
52.1
63.6
0.61
18
184
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
45
422
1.07
0.13
1.4
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
69
657
1.05
0.13
1.3
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
17
190
0.89
0.13
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
67
639
1.05
0.12
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
21
191
1.10
0.11
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
125
1290
0.97
0.11
1.7
2.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
16
143
1.12
0.11
1.1
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
59
619
0.95
0.11
1.5
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
272
2773
0.98
0.11
1.9
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
94
907
1.04
0.11
1.5
1.2
u/ml
3.5
3.3
0.05
31
285
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
44
416
1.06
0.11
1.0
1.1
mg/l
322.1
279.6
0.39
39
360
(3002256) Pathology report gross observation
866
8576
1.01
0.10
1.3
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
28
301
0.93
0.10
2.7
2.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
11
96
1.15
0.10
1.1
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
20
218
0.92
0.10
6.8
3.2
%
44.7
52.9
0.82
20
208
(3045142) Bone marrow Pathology biopsy report
77
742
1.04
0.10
1.2
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
63
656
0.96
0.09
1.5
1.6
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
51
534
0.95
0.09
2.0
1.9
mg/l
3.7
4.2
0.20
45
509
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
24
223
1.08
0.09
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
86
888
0.97
0.09
1.5
1.2
u/ml
2.5
4.2
2.34
42
378
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
17
155
1.10
0.09
1.1
1.3
nmol/l
180.7
127.6
0.84
11
112
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
54
1.11
0.09
3.7
6.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
6
55
1.09
0.08
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
175
0.91
0.08
1.3
3.3
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
5
60
0.83
0.08
1.8
1.2
mg/l
11.4
8.1
—
5
53
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
65
0.77
0.08
2.0
1.9
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
64
1.09
0.08
2.6
2.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
7
64
1.09
0.08
1.3
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
7
65
1.08
0.08
1.9
1.6
umol/l
60.9
42.0
—
7
65
(3027944) Amphetamines [Presence] in Urine
134
1370
0.98
0.08
1.6
2.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
725
7308
0.99
0.07
3.3
4.0
ug/l
28.7
23.6
0.12
567
5949
(3044242) Glucose [Moles/volume] in Arterial blood
34
323
1.05
0.07
1.4
2.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
169
1721
0.98
0.07
2.8
2.4
%
188.7
196.9
0.61
158
1635
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
47
489
0.96
0.07
1.4
1.5
g/l
0.9
1.0
0.09
47
489
(40765089) Chromosome analysis panel - Blood by G-banded
7
81
0.86
0.07
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
83
0.84
0.07
3.6
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
479
4744
1.01
0.07
1.4
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
29
306
0.95
0.07
4.5
3.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
169
1720
0.98
0.07
1.3
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
118
1.10
0.07
1.4
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
118
1.10
0.07
1.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
9
86
1.05
0.07
1.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
87
1.03
0.07
1.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
89
1.12
0.06
1.0
1.1
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
8
90
0.89
0.06
1.1
1.8
mmol/l
1.4
2.9
—
8
79
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
8
90
0.89
0.06
3.6
2.9
—
27.6
—
0
13
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
90
0.89
0.06
1.6
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
20
187
1.07
0.06
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
48
497
0.97
0.06
1.8
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
53
513
1.03
0.06
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
71
729
0.97
0.06
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
18
168
1.07
0.06
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
35
365
0.96
0.06
1.4
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
90
1.11
0.05
2.6
1.9
umol/l
12.0
17.8
—
10
90
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
26
273
0.95
0.05
1.4
2.1
umol/l
43.1
128.9
3.77
12
152
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
65
667
0.97
0.05
1.5
1.4
nmol/l
0.2
0.3
0.80
54
485
(4306422)
87
888
0.98
0.05
1.3
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
34
327
1.04
0.05
1.2
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
45
464
0.97
0.04
1.2
1.3
mmol/l
10.6
12.2
—
8
122
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
35
363
0.96
0.04
1.3
1.5
ug/l
2.2
4.3
1.60
26
278
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
199
1.06
0.04
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
53
516
1.03
0.04
1.4
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
147
1451
1.01
0.04
3.0
3.4
u/ml
607.1
657.1
0.03
133
1316
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
100
1016
0.98
0.04
1.2
1.2
u/l
23.6
39.0
2.21
83
885
(3000764) Benzodiazepines [Presence] in Urine
141
1393
1.01
0.03
1.6
2.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
141
1.06
0.03
1.3
1.3
—
—
—
0
0
(4133840)
15
141
1.06
0.03
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
51
498
1.02
0.03
1.7
2.1
%
11.6
11.1
0.49
51
498
(3016750) Collection duration of Urine
37
359
1.03
0.03
1.9
2.2
min
485.5
497.8
0.30
24
264
(3010421) pH of Blood
168
1697
0.99
0.03
4.0
4.1
ph
7.4
7.4
0.15
147
1430
(3009871) Measles virus Ab [Titer] in Serum
20
191
1.05
0.03
1.7
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
530
5278
1.00
0.03
7.3
7.9
—
—
—
0
0
(4268621)
62
609
1.02
0.02
2.7
2.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
15
158
0.95
0.02
1.5
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
54
530
1.02
0.02
1.5
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
36
351
1.03
0.02
1.5
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
40
391
1.02
0.02
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
31
318
0.97
0.01
3.7
3.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
12
127
0.94
0.01
1.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
141
1400
1.01
0.01
1.6
2.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
153
1.05
0.01
1.0
1.1
—
—
—
0
0
(4035726)
614
6126
1.00
0.01
1.4
1.4
—
—
—
0
0
(4027681)
33
323
1.02
0.01
1.2
1.2
—
—
—
0
0
(4211845)
35
343
1.02
0.01
3.5
3.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
38
387
0.98
0.01
1.1
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
46
453
1.02
0.01
2.1
2.0
ug/l
2.4
3.5
0.74
39
402
(3035320) C reactive protein [Mass/volume] in Body fluid
46
453
1.02
0.01
3.6
2.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
90
893
1.01
0.01
1.2
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
12
126
0.95
0.00
1.1
1.6
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
16
154
1.04
0.00
1.7
1.9
mmol/l
0.0
1.0
0.50
16
146
(3023487) Leukocytes [#/volume] in Peritoneal fluid
24
234
1.03
0.00
2.4
2.1
e6/l
436.9
4011.3
0.57
15
166
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
27
264
1.02
0.00
2.3
2.2
umol/l
51.4
55.1
0.26
20
213
(40760888) Immunoglobulin light chains.free panel - Serum
161
1604
1.00
0.00
3.0
3.4
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
12
123
0.98
0.00
1.0
1.1
—
5.1
—
0
14
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
96
1.04
0.00
1.4
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
43
433
0.99
0.00
6.7
6.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
77
773
1.00
0.00
2.9
2.3
mmol/l
4.0
4.0
0.09
77
763
(3035285) Chloride [Moles/volume] in Venous blood
77
773
1.00
0.00
2.9
2.3
mmol/l
105.5
105.4
0.03
77
763
(3016244) Insulin [Units/volume] in Serum or Plasma
31
314
0.99
0.00
3.4
3.1
mu/l
32.0
27.8
0.21
31
301
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
92
916
1.00
0.00
1.1
1.1
iu/ml
65.5
11547.5
0.55
17
207
(3028300) Cannabinoids [Presence] in Urine
141
1406
1.00
0.00
1.6
2.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
562
5617
1.00
0.00
6.2
6.6
mmol/l
1.4
1.3
0.70
546
5423
(3013293) Extractable nuclear Ab [Presence] in Serum
11
108
1.02
0.00
1.7
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
178
1.01
0.00
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
21
212
0.99
0.00
1.4
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
35
348
1.01
0.00
1.3
1.4
pmol/l
54.1
143.0
0.53
16
111
(3004775) Volume in Urine collected for unspecified duration
50
498
1.00
0.00
2.3
2.3
ml
679.9
639.2
0.21
31
333
(3033705) Calcium.ionized [Moles/volume] in Venous blood
76
758
1.00
0.00
2.9
2.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
13
129
1.01
0.00
2.1
1.9
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
13
129
1.01
0.00
8.1
4.1
u/l
38.8
67.8
—
5
45
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
16
159
1.01
0.00
1.3
1.3
ug/l
40.8
399.0
—
6
84
(3048879) Bone marrow aspiration report
19
191
0.99
0.00
2.4
1.9
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
34
339
1.00
0.00
1.9
1.9
u/field
3.1
2.7
0.13
26
240
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
32
319
1.00
0.00
4.0
3.9
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
44
441
1.00
0.00
2.2
2.1
ug/l
1.6
2.5
1.59
33
379
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
49
491
1.00
0.00
1.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
140
1401
1.00
0.00
3.5
3.6
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
1.2
—
0
9
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
91
0.99
0.00
1.8
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
7
70
1.00
0.00
1.0
1.0
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
18
180
1.00
0.00
1.1
1.1
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
84
0.95
0.00
1.1
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
55
0.91
0.00
3.0
2.3
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
16.7
—
0
6
(3012898) Urea [Moles/volume] in Urine
6
60
1.00
0.00
1.2
1.3
mmol/l
123.0
169.8
—
6
50
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
68
0.88
0.00
1.2
1.3
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
0.5
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
7
0.00
0.00
0.0
2.4
—
5.3
—
0
7
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
186
1860
1.00
0.00
2.4
2.1
%
89.9
91.6
0.47
175
1731
(3034092) Cytoplasmic Ig cells/100 cells in Blood
7
78
0.90
0.00
5.3
10.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
57
0.88
0.00
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
80
1.00
0.00
1.0
1.2
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
59
1.02
0.00
1.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
80
1.00
0.00
1.0
1.2
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
59
1.02
0.00
1.7
2.2
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
80
1.00
0.00
1.0
1.2
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: L12_LICHENPLANUS_INCLAVO – Lichen planus, including avohilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).